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Abstract:  
  
In recent years, there was growing evidence that Calbindin-D28k, a common calcium 
binding protein, highly conserved among mammals, might be cytoprotective by 
inhibiting active Caspase-3, an important effector of apoptosis and, thereby, a crucial 
factor in cell physiology, oncogenesis and neurodegenerative diseases. Few in-vitro 
studies suggested that there might also be an interaction with the pro-domain of its 
zymogen, Pro-Caspase-3. To date, evidence on the various intermolecular interactions 
of Calbindin-D28k is essentially based on in-vitro studies. However, occasionally  
in-vitro studies yield results that might not correspond with conditions in living cells. 
To our knowledge, it is the first time that the proposed intermolecular Calbindin-D28k-
Pro-Caspase-3 interaction and, moreover, the inhibition of Caspase-3 activity in a 
more complex, natural milieu of a cell is investigated using in-situ FRET microscopy 
(Acceptor-Photobleaching and Sensitized Emission). There is conclusive evidence for 
a calcium-independent interaction between Calbindin-D28k and an Inositol 
monophosphatase (IMPase) peptide sequence. Contrary to previous in-vitro studies 
based on peptide sequences, these results do not indicate an interaction with Pro-
Caspase-3 regardless of intracellular calcium levels. This finding suggests that the 
inhibition of Caspase-3 activity is attributable to the intermolecular interaction with 
active Caspase-3. Moreover, the current findings indicate inhibition of Caspase-3 
activity in a concentration-dependent manner. Further understanding of these 
cytoprotective pathways and mechanisms might prove beneficial to develop new 
cytoprotective or radio-/chemosensitizing agents and therapeutic strategies to 
modulate programmed cell death in neurodegenerative diseases, such as Morbus 
Alzheimer, Chorea Huntington or Amyotrophic lateral sclerosis, and various tumor 
diseases. 
Keywords: 
calbindin, calcium binding protein, caspase, apoptosis, modulation, interaction, inhibition, 
cytoprotection, FRET, förster resonance energy transfer, photobleaching, sensitized emission, 
photoconversion, biosensor, caspase activity, neuron, hippocampus, inositol monophosphatase 
 
 
Deutschsprachige Kurzfassung: 
  
Calbindin-D28k ist ein hoch konserviertes Kalzium-bindendes Protein, dem ein 
protektiver Effekt zugesprochen wird. In-vitro Studien haben gezeigt, dass Calbindin-
D28k in der Lage ist, die aktive Caspase-3 zu hemmen, ein wichtiger Effektor des 
programmierten Zelltodes, die eine Schlüsselrolle in Zellphysiologie, Tumorentstehung 
und neurodegenerativen Erkrankungen einnimmt. Wenige in-vitro Studien haben 
ebenso zeigen können, dass eine Interaktion mit dem Zymogen, der Pro-Caspase-3, 
möglich ist. Bis heute stützt sich nahezu die gesamte Beweislage zu den 
verschiedenen intermolekularen Interaktionen von Calbindin-D28k im Wesentlichen 
auf in-vitro Studien. Jedoch können in-vitro Studien vereinzelt Ergebnisse 
hervorbringen, die sich nicht auf das komplexe Milieu von lebenden Zellen übertragen 
lassen. Daher untersucht die vorliegende Forschungsarbeit, die Calbindin-D28k-Pro-
Caspase-3 Interaktion und die Inhibition der Caspase-3 Aktivität im komplexeren 
Milieu einer Zelle mittels in-situ FRET-Mikroskopie (Acceptor-Photobleaching und 
Sensitized Emission). Die Daten weisen auf eine Kalzium-unabhängige Interaktion 
zwischen Calbindin-D28k und einem Peptid der Inositol monophosphatase (IMPase) 
hin. Allerdings können die Ergebnisse, unabhängig von der intrazellulären Kalzium-
Konzentration, keine Interaktion mit der Pro-Caspase-3 bestätigen. Diese Ergebnisse 
stehen im Gegensatz zu in-vitro Studien, die eine Interaktion mit den jeweiligen 
Peptidsequenzen zeigen konnten. Dies legt nahe, dass die Inhibition der Caspase-3 
Aktivität auf die intermolekulare Interaktion mit der aktiven Caspase-3 zurückzuführen 
ist. Die Ergebnisse sprechen außerdem für eine konzentrationsabhängige Hemmung 
der Caspase-3 Aktivität. Ein tieferes Verständnis der protektiven Signalwege und 
Funktionsweisen kann bei der Entwicklung von neuen protektiven oder radio-
/chemosensibilisierenden Pharmaka und therapeutischen Behandlungsstrategien 
richtungsweisend sein, die den programmierten Zelltod in neurodegenerativen 
Erkrankungen, wie Morbus Alzheimer, Chorea Huntington oder Amyotrophe 
Lateralsklerose, aber auch diversen Tumorerkrankungen modulieren könnten.  
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1 
1. Introduction 
1.1. Calbindin-D28k (CBD28k) 
Calbindin-D28k (CBD28k), first discovered in 1966 
in chick intestinal mucosa (Wasserman & Taylor 
1966), belongs to the family branch sharing an 
EF-hand motif, among more than 200 calcium-
binding proteins (CBPs). Its sequence, genetically 
encoded by CALB1, is highly conserved among 
mammals and predominantly expressed in 
neurons. CBD28k constitutes up to 1.5 % of the 
total soluble brain protein (Berggård et al. 2002a),  
particularly abundant in cerebellar Purkinje cells (Barski et al. 2003), hippocampal 
granule cells (Iritani et al. 2001)  and neocortical interneurons, but was also reported in 
bone, kidney, pancreas and other tissues (Christakos et al. 1989). Besides Calcitriol, 
neurotrophins (NT-3, BDNFa), IGF-1 and fibroblast growth factor were reported to 
stimulate expression of CBD28k (Collazo et al. 1992, Murayama et al. 2015, Nieto-Bona 
& Busiguina 1995, Wasserman & Fullmer 1989). 
Featuring 6 EF-hands of which 4 are considered functional (see figure 1), CBD28k forms 
a single globular domain (Kojetin et al. 2006), facilitating calcium binding with low 
cooperativity, medium affinity and medium to fast kinetics (Schmidt 2012). In resting 
state, its binding sites are primarily occupied by magnesium (Berggård et al. 2002a), 
whereas with increasing intracellular calcium concentration, it unbinds magnesium to 
bind calcium, limiting intracellular increases in calcium levels (Schmidt 2012). It is 
considered a calcium sensor, buffer and transporter (see figure 2), as it regulates 
calcium-dependent downstream signaling, controls spatiotemporal calcium dynamics 
and homeostasis by transporting free calcium within intracellular compartments 
(Berggård et al. 2002a). 
Furthermore, there are findings suggesting a role in a wide range of physiological 
processes, such as Long-Term-Potentiation (LTP) (Molinari et al. 1996) and cerebellar 
motor coordination (Airaksinen et al. 1997a).  
 
 
Figure 1. Structure of Calbindin-D28k. 
CBD28k (~ 30 kDa) displayed using Jmol and 
colored according to groups. [PDB 2F33, 
(Kojetin et al. 2006)] 
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Centrifugation and electron microscopic studies have shown that CBD28k is 
predominantly located in the cytosolic fraction. However, there are inconsistent reports 
of an association with fractions such as the nuclear fraction, mitochondria, endoplasmic 
reticulum, synaptic membranes, synaptic vehicles and the cerebellar microsomal 
fraction. Interestingly, decreased membrane fraction association at low calcium levels, 
indicated an interaction with membrane associated target molecules at increased 
calcium levels (Winsky & Kuźnicki 1995). 
 
 
 
Figure 2. Calbindin-D28k and its function as a buffer, transporter and sensor. 
CBD28k is demonstrated exhibiting its common buffer and transporter function (left section) during calcium influx. 
Upon binding calcium, CBD28k undergoes conformational change. This leads to exposed hydrophobic regions, that 
facilitate interaction with other proteins. This behavior (middle section) is typical for canonical sensors. At resting 
state, CBD28k is predominantly saturated with magnesium. It was shown that regardless of its saturation, CBD28k 
exposes a hydrophobic region, which facilitates calcium-independent interaction (right section). 
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1.1.1. EF-hand motif 
The EF-hand motif is a highly conserved helix-loop-
helix structural domain that is common in many 
CBPs. The perpendicularly oriented alpha helices 
resemble an outstretched thumb (F-helix) and index 
finger (E-helix), connecting a loop, which forms a 
binding site for calcium (see figure 3). Calcium ions 
are bound by both negatively charged amino acid 
residues, namely aspartate and glutamate, and 
protein backbone atoms (Johnson et al. 2014). 
After its discovery in Parvalbumin (Kretsinger & 
Nockolds 1973), many CBPs were found with varying 
numbers of EF-hands such as Troponin-C and 
Calmodulin, each with 4 EF-hand motifs, or Calretinin and CBD28k, each with 6 EF-hand 
motifs. Dependent on the number of EF-hand motifs and the differentiation in 
canonical/regulatory and structural/pseudo EF-hands, many EF-hand motif family 
branches are distinguished (Heizmann 1992). Regulatory EF-hands typically induce 
conformational changes, whereas structural EF-hands are restricted to calcium 
buffering and transport. 
1.1.2. Cytoprotection 
Substantial calcium level fluctuation is known to be a trigger of apoptosis. Therefore, 
calcium buffering can protect cells from Calpain-mediated activation of Caspase-3 
(Pochet et al. 2000, Sharma & Rohrer 2004). Correspondingly, several studies reported 
cytoprotective effects upon CBD28k expression (Burke & Baimbridge 1993, Iacopino et 
al. 1992, Mattson et al. 1991). However, there was growing evidence that an alternate 
calcium-independent cytoprotective pathway exists, which involves the inhibition of 
Caspase-3 (Bellido et al. 2000, Choi et al. 2008, Christakos & Liu 2004, Liu et al. 2003). 
To date, CBD28k is the only endogenous, non-oncogenic Caspase-3 inhibitor besides 
the inhibitors of apoptosis (IAP) (Christakos & Liu 2004).  
 
Figure 3. EF-hand motif. 
Calcium is chelated in a loop (red, phalanx 
3 - 5) connecting the F-helix (blue, thumb) 
and the E-helix (yellow, index finger), 
which are oriented perpendicular to each 
other. (adapted from (Berg et al. 2012) 
(pp445)). 
4 
1.1.3. Intermolecular interaction 
Upon binding calcium, CBD28k undergoes conformational change that leads to exposed 
hydrophobic regions, which facilitate protein-protein interaction. However, it was 
shown that in its apo-state (unloaded state), a hydrophobic region, corresponding to 
EF-hand 2,  is permanently exposed, suggesting that CBD28k might additionally interact 
in a calcium-independent manner (Schmidt 2012). 
To date, a wide array of proteins was reported to interact with CBD28k. Among the 
various interaction partners are Ca2+-Mg2+-ATPase (Morgan et al. 1986), 3’-5’-cyclic 
nucleotide phosphodiesterase (Reisner et al. 1992), Ran-binding-protein-M (RanBPM) 
(Lutz et al. 2003), TRPV5 channel (Lambers et al. 2006), Alkaline phosphatase (Norman 
& Leathers 1982), polypeptide Mellitin (La Bella et al. 1996), Myo-inositol 
monophosphatase-1 (IMPase-1) (Schmidt et al. 2005) and Pro-/Caspase-3 (Bellido et al. 
2000, Kojetin et al. 2006). However, to date, the evidence on interaction partners is still 
essentially based on cell-free systems.  
Inositol monophosphatase (IMPase) 
As reported in various studies, there is evidence for an interaction site in Mus musculus 
lithium-sensitive Myo-inositol monophosphatase A1 (IMPase1), which shows activity 
enhancement upon binding CBD28k (Almog et al. 2011, Berggård et al. 2002b, Schmidt 
et al. 2005). Dephosphorylating inositol monophosphate (IP) to myo-inositol and 
inorganic phosphate, IMPase1 is of importance to the phosphatidylinositol (PI) signaling 
pathway (Hallcher & Sherman 1980) and might be involved in the mood stabilizing 
effect of lithium according to the inositol depletion hypothesis (Almog et al. 2011, Klein 
& Melton 1996). 
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Caspase-3 
Caspase-3 belongs to a family of cysteine-aspartic 
acid proteases, which can induce apoptosis and, 
therefore, play an important role in programmed 
cell death (PCD). Synthesized as a zymogen,  
Pro-Caspase-3 undergoes a proteolytic conversion 
to its active form once the common apoptotic 
pathway is triggered. Later, its activation leads to 
the cleavage of essential cellular proteins, which 
ultimately results in cell death. 
In recent years, various studies provided evidence 
for a CBD28k-mediated inhibition of Caspase-3 
(Bellido et al. 2000, Bobay et al. 2012, Choi et al. 
2008, Christakos & Liu 2004, Kojetin et al. 2006, 
Liu et al. 2003). It was shown that contrary to other 
common CBPs, such as Calmodulin and Calbindin-
9K, only CBD28k was capable of inhibiting 
Caspase-3 activity (see figure 4). Furthermore, from active caspases 1 - 10, only active 
Caspase-3 was affected by CBD28k in a concentration-dependent manner (Liu et al. 
2003). Using glutathione-S-transferase (GST) pull down assays, it was demonstrated 
that CBD28k can directly bind mature, active Caspase-3 (Christakos & Liu 2004). 
Another study revealed that the mechanism underlying the inhibition is substrate 
access restriction to the catalytic site and change of loop regions within Caspase-3. 
While previous reports proposed that the interaction occurs in a calcium-independent 
manner (Bellido et al. 2000, Liu et al. 2003), this study also provided evidence that the 
binding might not occur in apo-state (Bobay et al. 2012).  
However, there were few reports suggesting that the interaction might also occur with 
its precursor, Pro-Caspase-3 (Bellido et al. 2000). Based on NMR studies and homology 
searches, an interaction site within the pro-domain was suggested, featuring a 
sequence (SKSIKNLEP) similar to RanBPM (LASIKNR) and IMPase (ISSIKEKYPSHS) target 
peptide sequences. Consequently, it was proposed that inhibition might occur by 
 
Figure 4. Caspase-3 and CBD28k complex. 
Catalytic residues are demonstrated as 
spheres within Caspase-3. EF-hands are 
colored red (EF-hand 1), orange (EF-hand 2), 
yellow (EF-hand 3), green (EF-hand 4), blue 
(EF-hand 5), purple (EF-hand 6). (adapted and 
modified from (Bobay et al. 2012)). 
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interception of pro-domain cleavage, which is essential for Caspase-3 maturation 
(Kojetin et al. 2006). Another study provided similar evidence (Kordys et al. 2007).  
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1.2. Apoptosis 
Apoptosis (apóptōsis; from Ancient Greek; "a falling off") is an essential and, therefore, 
highly conserved mechanism mediating programmed cell death (PCD) in multicellular 
organisms. Its key role in balancing growth and death upon physiologic and pathological 
stimuli is important in regular cell physiology, embryogenesis and various other 
developmental changes, particularly the maturation of the nervous and immune 
system, oncogenesis, aging, tissue repair, inflammation and infection. Dysfunction and 
imbalance of apoptosis, resulting either in massive over-proliferation or induction of 
excessive cell death, usually lead to various severe diseases, such as Alzheimer’s 
disease (AD), Parkinson’s disease (PD), several autoimmune diseases, ischemia, 
acquired immunodeficiency syndrome (AIDS) or cancer (Elmore 2007). 
The necrosis-apoptosis continuum describes a theory that is based on the assumption 
that dependent on the circumstances, cell death might occur in a carefully regulated 
fashion, such as in apoptosis, or in an uncoordinated manner, such as in necrosis. 
Particularly the availability of caspases and energy in form of adenosine triphosphate 
(ATP), but also the developmental stage, tissue type, cytotoxic stimuli and its dose 
determine which pathway eventually dominates. Both types of cell death are 
associated with distinct morphological and biochemical changes. Necrosis is induced by 
external factors, such as lack of energy or cell membrane damage and affects groups 
of contiguous cells. It is typically characterized by cell lysis, inflammation, metabolic and 
homeostatic collapse, random DNA fragmentation and cell swelling. In contrary, 
apoptosis affects individual cells due to extrinsic or intrinsic physiological stimuli and 
leads to an energy-dependent, regulated, non-inflammatory response with chromatin 
condensation (CD), cell fragmentation and, subsequently, phagocytosis (Elmore 2007).  
In recent years, there was growing evidence that there are other pathways available 
mediating PCD, all featuring their own phenotypes and biochemical mechanisms 
compared with classical apoptosis (Elmore 2007). Aponecrosis is a form of PCD that 
shows morphological changes of both necrosis and apoptosis (Formigli et al. 2000). 
Caspase-independent cell death (CICD) was found in distinct neuronal cells that leads 
to characteristic apoptotic changes although the caspase-dependent pathways were 
previously inhibited (Volbracht et al. 2001). 
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Both intrinsic/mitochondrial-mediated and extrinsic/death receptor-mediated signaling 
(see figure 5) can lead to the activation of the caspase-dependent cascade. Caspases 
can be categorized in 2 groups, the initiators (Caspase-8, -9, and -10) that activate the 
respective effectors (Caspase-3, -6, and -7), ultimately leading to cleavage of several 
intracellular proteins (Li & Yuan 2008). 
Extrinsic pathway 
The extrinsic pathway is characterized by cell surface ligand binding. Ligands, such as 
tumor necrosis factor alpha (TNF-alpha) or FAS, binding to death receptors, induce the 
oligomerization of receptors and the recruitment of death domain-containing adaptor 
proteins, such as Pro-Caspase-8 and -10. The accumulation and clustering of Pro-
Caspases near these receptors leads to a death-inducing signaling complex (DISC). 
Within this multi-protein complex, Pro-Caspase-8 and -10 undergo autoactivation by 
cleavage, resulting in downstream caspase activation (Li & Yuan 2008).  
 
 
 
Figure 5. Apoptosis: Extrinsic and intrinsic pathway. 
(adapted and modified from (Kumar et al. 2014) (pp74)). 
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Intrinsic pathway 
The intrinsic pathway is triggered by internal stress signals, such as DNA damage, 
leading to destabilization of the mitochondrial membrane. Changes within its integrity 
and permeability, result in an imbalance between pro- and anti-apoptotic Bcl-2-family 
proteins, which can consequently trigger apoptosis. The cytoplasmic release of pro-
apoptotic proteins, such as Cytochrome c, leads to the formation of a protein complex, 
the apoptosome (Cytochrome c and APAF-1), which recruits Pro-Caspase-9 and initiates 
its activation. Alternatively, in the case of DNA damage, Caspase-2 activation might 
occur within the PIDDosome in a p53-dependent manner (Li & Yuan 2008). 
Common pathway 
The active initiator caspases then subsequently lead to activation of effector Pro-
Caspases-3, -6 and -7. The active effector caspases then target various essential cellular 
proteins, which ultimately leads to the disassembly of the cell. 
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1.3. Förster resonance energy transfer (FRET) 
1.3.1. Theoretical background of FRET  
Förster’s theory, published in the 
1940s, contributed to a great extent to 
the advancements made in the field of 
microscopy imaging. 
Förster resonance energy transfer 
(FRET) describes a non-radiative 
transfer of excitation energy (see 
figure 6) from an excited donor to an 
acceptor molecule leading to a 
decrease of the donor quantum yield 
and donor excitation lifetime. As a 
result, the acceptor molecule shows 
sensitized acceptor emission, if 
fluorescent. However, this form of 
energy transfer occurs only if distinct 
conditions are met (Day & Davidson 2012): 
 Close proximity (10 - 100 Ångström): At close range of up to 10 nm energy can 
be transmitted. 
 Spectral overlap: This non-radiative energy transfer requires the overlap between 
the wavelength spectrums of both fluorophores, the donor emission spectrum and 
the acceptor absorption spectrum. 
 Transition dipole orientations: The emission and absorption transition dipoles need 
to be in a favorable orientation ((k2 = 0 - 4) towards each other, namely side-by-
side (k2 = 1) or head-to-tail (k2 = 4). Usually k2 is assumed to be 2/3 (Day & Davidson 
2012, Sun et al. 2010). 
 Quantum yield of the donor: The ratio of photons emitted to the photons absorbed 
should be reasonably high. 
 
 
 
Figure 6. Simplified Jablonski diagram. 
The absorption of energy leads to a switch from electronic 
ground state (D) to an excited state (D*). After relaxation 
(dotted arrow) to an excited ground state, further relaxation to 
the electronic ground state occurs through 
fluorescence/radiation (kR) or non-radiative decay (kNR) or 
non-radiative FRET (kFRET). Only if resonance conditions are 
met, energy is transferred to the acceptor protein, leading to 
an excited state (A*) of the acceptor protein. To return to its 
ground state (A), energy is once again emitted by radiation (kR) 
or in a non-radiative manner (kNR). (adapted from (Medintz & 
Hildebrandt 2013) (pp109)). 
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Förster regarded donors as linked electrical oscillators with an electrical field with 4 
zones: starting with the inner zone, then the Dexter or contact zone, followed by the 
near-field zone within a range of 1 - 10 nm from the donor, where the Förster theory 
applies, and, at last, the intermediate zone (10 - 1000 nm from the donor) and far field 
or electromagnetic radiation zone. The basic theory of resonance declares that a 
vibrating/oscillating system can cause another system to vibrate/oscillate when specific 
resonance frequencies are met. In the case of FRET: the donor, excited by an 
electromagnetic field caused by photons/light, oscillates and creates an 
electromagnetic field, which in turn drives the acceptor to oscillate. This oscillating 
electromagnetic dipole-interaction (Coulomb interaction) in the near-field zone is the 
foundation of the energy transfer (Medintz & Hildebrandt 2013) (pp31-37). 
Förster’s formula states that FRET-efficiency 
(E) is strongly dependent on the inverse of the 
6th power of the distance (rDA) and the Förster 
radius (R0) (see figure 7). Consequently, energy 
transfer occurs only if both fluorescent 
proteins (FPs) are in nanometer scale 
proximity to each other. Determination of the 
overlap integral (J) can be used to calculate the 
Förster distance (R0) of the respective donor 
and acceptor pair, typically displaying values 
from 2 - 8 nm (Padilla-Parra & Tramier 2012). 
Knowing both the FRET-efficiency (E) and 
Förster distance (R0), the distance between 
donor and acceptor (rDA) can be determined. 
  
 
Figure 7. FRET-efficiency in dependence of the 
fluorophore distance. 
R0 is the Förster distance at which 50 % of the 
energy of the excited donor is transferred to the 
acceptor. This dependence explains the sensitivity 
of the FRET-efficiency (E) to the distance (rDA) in 
the 0.5 - 2.0 R0 range. It is advisable to choose a 
FRET pair with a R0 value within the range 
mentioned above. (adapted from (Medintz & 
Hildebrandt 2013) (pp110)). 
12 
Conclusions of Förster’s theory in mathematical terms: 
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(adapted from (Medintz & Hildebrandt 2013) (pp26)). 
 
E Transfer efficiency 
kt Rate of FRET energy transfer 
τD Lifetime of donor excited state in the absence of acceptor 
rDA Donor and acceptor distance 
R0 Förster distance at which 50 % (E = 50 %) of the energy of the excited 
donor is transferred to the acceptor. 
ln10 2.302585093 
κ2 Orientation factor (in intermolecular applications approximately 2/3) 
ΦD Quantum yield of the donor fluorescence in the absence of acceptor 
J Overlap integral 
π 3.14159 
n Refractive index of the medium 
NA 6.0221415 x 1023 per mole (Avogadro's number) 
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1.3.2. FRET microscopy 
In the last few decades, a wide array of methods and dedicated equipment for different 
FRET applications were developed. Essentially, 2 major groups of methods are 
distinguished: implementations based on donor quenching and acceptor sensitization, 
such as Acceptor-Photobleaching, Sensitized Emission, Fluorescence Lifetime Imaging 
Microscopy/FLIM, and emission anisotropy-based procedures (Jares-Erijman & Jovin 
2003). Ever since, FRET proved to be exceptionally useful for a range of applications 
such as the monitoring of protein-protein interaction, conformational changes and 
biochemical activity (see figure 8). Contrary to other commonly applied approaches for 
the assay of intermolecular association, FRET applications enable the user to increase 
the spatial resolution of confocal microscopy and, moreover, acquire reliable data within 
the natural, cellular environment. As its occurrence is limited to close spatial proximity 
of 10 - 100 angstrom, FRET commonly implies molecular association and direct 
interaction (Bastiaens & Pepperkok 2000, Grecco & Verveer 2011, Sekar & Periasamy 
2003). 
  
 
 
Figure 8. Applications of FRET: Monitoring of protein-protein interaction and biochemical 
activity. 
Protein-protein interaction between 2 fusion constructs, mAmetrine (FP) linked to Calbindin-D28k 
and tdTomato (FP) linked to Pro-Caspase-3, can be assayed using FRET. Intramolecular FRET is 
demonstrated for a Caspase-3 bio-sensor. Cleavage of the characteristic DEVD motif leads to 
decreased FRET-efficiency during apoptosis. 
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1.3.2.1. Acceptor-Photobleaching (PB) 
Among the methods at choice, Acceptor-Photobleaching (PB) is a reliable, accurate and 
straightforward solution for measuring protein co-localization. If FRET occurs, the 
original signal should be decreased due to energy transfer to the acceptor. Then, the 
acceptor molecules are irreversibly bleached by strong irradiation to approximately 1/10 
of their initial intensity. In the absence of energy transfer, the donor population shows 
increased signal, which is commonly described as dequenching. If necessary, a 
corrective approach for crosstalk and other artefacts should be applied. The FRET-
efficiency is quantified with the following formula: 
 
  
  
 
POST PRE
POST
I Itransfer of energy
E
donor excitation I

   
(adapted from (Bastiaens et al. 1995, 
Gadella & Jovin 1995)) 
IPOST Donor intensity after the bleaching event 
IPRE Donor intensity before the bleaching event 
 
Advantages of Photobleaching: 
 simple method 
 implementation with most confocal microscope systems 
 accurate measurement, as the determination of quenched and 
unquenched donor signal is performed on the same specimen 
 not generally affected by spectral bleed-through (SBT) 
Limitations of Photobleaching: 
 can be used only once per cell due to its destructive nature 
 limited to immobile or fixated cells 
 non-dynamic measurement 
 slow bleaching event might be accompanied by protein 
movement 
 possible photoconversion 
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1.3.2.2. Sensitized Emission (SE) 
Sensitized Emission (SE) is one of the easiest and frequently used methods to detect 
FRET. Due to its simplicity and non-destructive nature, it is commonly preferred. 
However, Sensitized Emission is considered to be less robust and, therefore, is primarily 
applied in qualitative research. Sensitized Emission describes the increase in acceptor 
emission upon donor excitation, provided that FRET occurs. FRET-efficiency is then 
calculated based on the change of intensity.  
Commonly, 3 samples (Acceptor-only control, Donor-only control and FRET sample) and 
3 filter sets (Acceptor filter set, Donor filter set and FRET filter set) are required. Based 
on the control samples, correction factors need to be determined, which account for 
crosstalk, concentration differences and artefacts. Among the different corrective 
approaches available, normalized FRET (nFRET) was calculated, as it corrects for 
emission crosstalk, cross excitation and, additionally, all values are normalized for the 
concentration of donor and acceptor (Xia & Liu 2001). 
 
- ( ) - ( )DA A AA D DD
AA DD
I R I R I
nFRET
I I
 


 
(adapted from (Gordon et al. 1998, Xia & 
Liu 2001)) 
IDA Donor excitation and acceptor detection 
IAA Acceptor excitation and acceptor detection 
IDD Donor excitation and donor detection 
 
RA Acceptor correction factor: 
DA
AA
I
I
 (acquired from Acceptor-only samples) 
 
RD Donor correction factor: 
DA
DD
I
I
  (acquired from Donor-only samples) 
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Advantages of Sensitized Emission 
 simple method 
 non-destructive 
 dynamic measurement 
 not generally affected by spectral bleed-through 
Limitations of Sensitized Emission: 
 extensive control experiments 
 correction of crosstalk and cross excitation 
 quantitatively inaccurate measurement 
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1.3.3. Fluorescent proteins (FPs) 
The discovery of Green Fluorescent Protein (GFP), one of the most popular fluorophores 
in life sciences research, had great impact on microscopy after its isolation from jellyfish 
Aequorea Victoria in 1922 (Prasher et al. 1992). Early FRET studies were predominantly 
performed with GFP and its variants (Romoser et al. 1997). However, today, a vast 
variety of fluorescent proteins (FPs) is available with distinct characteristics and 
applications. Like GFP, all FPs known to date feature a chromophore within a helical 
segment in the center of a characteristic β-barrel (11 β-sheets) fold (see figure 9). 
 
 
mAmetrine and tdTomato FP pair 
With regard to stability in an apoptotic environment, negligible excitation bleed-through 
(unwanted direct acceptor excitation at the donor wavelength) and minimal cross talk 
(detection of donor emission in the acceptor channel), the FP pair was chosen to be 
mAmetrine and tdTomato (see figure 10 and table 1). Both FPs are considered fairly pH-
 
Figure 9. Structure of GFP and its chemical changes during fluorescence. 
Chemical modification of the Ser-Tyr-Gly sequence leads to green fluorescence in GFP 
(27 kDa) after excitation with ultraviolet or blue light. (adapted from (Berg et al. 2012) 
(pp92)). 
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insensitive, which makes them suitable for experiments in apoptotic environments 
(Medintz & Hildebrandt 2013, Miyawaki 2011). The FP pair was isolated from a FRET 
Caspase-3 biosensor from the group of Hui-Wang Ai and Robert E. Campbell (Ai et al. 
2008). 
 
mAmetrine is an Aequorea GFP variant with a large stoke’s shift (difference between 
the peak emission and excitation wavelengths) and modest photostability. It features 
violet excitation (406 nm) and yellow emission (526 nm) wavelengths (Ai et al. 2008). 
If paired with a red or orange fluorescent protein, the risk of unwanted cross-excitation 
becomes negligible.  
tdTomato, a variant of DsRed, is a highly photostable (intramolecular) tandem dimer 
(excitation at 554 nm; emission at 581 nm), exhibiting monomeric behavior, and is 
considered one of the brightest red-shifted FPs. It was particularly designed to show 
Table 1. Properties of fluorescent proteins. 
Fluorophore λ Peak-Em (nm) λ Peak-Abs (nm) ε (103 M–1 cm–1) φ 
mAmetrine 526 406 45 0.58 
tdTomato 581 554 138 0.69 
mTurquoise2 474 434 30 0.93 
 
Note:  
ε: extinction coefficient (absorbance of electromagnetic radiation based on the Beer-Lambert law).  
φ: quantum yield (probability of photon emission in excited state).  
(data adapted from (Ai et al. 2008, Goedhart et al. 2012)). 
 
 
 
Figure 10. Fluorophore spectra of mAmetrine, tdTomato and mTurquoise2. 
Datasets from (Ai et al. 2008, Goedhart et al. 2012).  
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good maturation and minimal aggregation and allows both N- and C-terminal fusions  
but may render the target protein dysfunctional due to its large size (Shaner et al. 2004).  
1.3.4. FRET Caspase-3 biosensor 
Most FRET biosensors are built from linking 
fluorophores to opposite ends of a target 
peptide. mAmetrine-DEVD-tdTomato is an 
intramolecular FRET construct devised to 
monitor Caspase-3 activity (Ai et al. 2008). 
Once cleavage of the DEVD (Asp-Glu-Val-Asp) 
target peptide sequence occurs, a decrease in 
FRET can be observed (see figure 11). 
  
 
 
Figure 11. Caspase-3 biosensor. 
After the cleavage of the intramolecular construct, 
the absence of FRET results in increased intensity 
in the mAmetrine channel and decreased intensity 
in the tdTomato channel. (adapted and modified 
from (Ai et al. 2008)). 
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1.4. Research objectives 
1.4.1. Pilot experiment: In-situ assay of Caspase-3 activity upon 
expression of Calbindin-D28k 
As of yet, evidence on the inhibition of Caspase-3 activity induced by CBD28k is still 
limited to in-vitro experiments. Restricted to a far less complex environment, in-vitro 
studies were occasionally shown to yield results that might not correspond with 
conditions in living cells. Thus, in-vivo/in-situ research is often necessary to confirm 
that these results are not limited to artificial circumstances. With the objective of 
providing a proof-of-concept experiment for investigating the proposed inhibition of 
Caspase-3 activity upon expression of CBD28k, quantitative Acceptor-Photobleaching 
experiments based on the intramolecular Caspase-3 biosensor with optional STS-
treatment were carried out (see table 2). Caspase-dependent aggregation of chromatin 
(CD) as dense spherical masses, peripheral to the nucleus, was used as a morphological 
marker for apoptosis (Jäättelä & Tschopp 2003). For further investigation, the original 
experiment was adjusted and replicated with FP-labeled CBD28k, facilitating screening 
for co-transfection and quantification of plasmid expression. 
 
 
Table 2. Experimental setup: Caspase-3 activity upon expression of Calbindin-D28k. 
Experiments Samples 
Unlabeled 
CBD28k 
mAmetrine-DEVD-tdTomato  
mAmetrine-DEVD-tdTomato + STS 10 µM, 11 hours w/ CD 
mAmetrine-DEVD-tdTomato + STS 10 µM, 11 hours w/o CD 
mAmetrine-DEVD-tdTomato + unlinked CBD28k 
mAmetrine-DEVD-tdTomato + unlinked CBD28k + STS 10 µM, 11 hours 
w/ CD 
mAmetrine-DEVD-tdTomato + unlinked CBD28k + STS 10 µM, 11 hours 
w/o CD 
FP-labeled 
CBD28k 
mAmetrine-DEVD-tdTomato  
mAmetrine-DEVD-tdTomato + mturq2-CBD28k 
mAmetrine-DEVD-tdTomato + mturq2-CBD28k + STS 15 µM, 4 hours 
w/o CD  
mAmetrine-DEVD-tdTomato + mturq2-CBD28k + STS 15 µM, 4 hours 
w/ CD 
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1.4.2. Investigation of intermolecular interaction between  
Calbindin-D28k and Pro-Caspase-3 by Acceptor-Photobleaching and 
Sensitized Emission 
Based on evidence suggesting a possible interaction between CBD28k and Pro-
Caspase-3 (Kojetin et al. 2006, Kordys et al. 2007), an intermolecular FRET experiment 
was carried out to investigate this association. Using the structural information available, 
donor (D) and acceptor (A) constructs were designed, linking target proteins with 
genetically-encoded FPs. In order to investigate if the occurrence of apoptosis and the 
conformational change of CBD28k upon calcium binding might have an effect on these 
interactions, cells were additionally treated with Ionomycin (INM) in order to raise 
intracellular calcium levels (see table 3). 
Due to evidence on the interaction between CBD28k and IMPase (Almog et al. 2011), 
an intermolecular FRET experiment with an IMPase peptide sequence was additionally 
prepared. 
 
  
Table 3. Experimental setup: Intermolecular interaction between Calbindin-D28k (CBD28k) and Pro-
Caspase-3 (CASP3) by Acceptor-Photobleaching and Sensitized Emission. 
Experiments Samples 
Controls Untransfected cells 
mAmetrine-CBD28k (D) 
tdTomato-CASP3 (A) 
mAmetrine-DEVD-TdTomato (positive control) 
Unconjugated FPs (negative control) 
mAmetrine-CBD28k and tdTomato (negative control) 
mAmetrine and tdTomato-CASP3 (negative control) 
FRET mAmetrine-CBD28k (D) and tdTomato-CASP3 (A)  
± INM 2 µM, 24 hours 
mAmetrine-CBD28k (D) and tdTomato-pIMPase (A)  
± INM 2 µM, 24 hours 
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2. Materials and methods 
Following section is a documentation of materials/software, which are referenced 
hereafter. 
(A) Plasmids: 
 pmAmetrine-DEVD-tdTomato (Addgene plasmid #18879) and mAmetrine-C1 
(Addgene plasmid #54660) (Ai et al. 2008) was a gift from Robert Campbell & 
Michael Davidson. 
 tdTomato-N1 was a gift from Michael Davidson & Roger Tsien (Addgene plasmid 
#54642). 
 Calbindin-D28k cDNA originally obtained from Harry Orr (Plasmid pCD2915) 
(Nordquist et al. 1988). 
 Caspase-3 was obtained from Source Bioscience LifeSciences, Cambridge, UK 
(RIKEN FANTOM clone ID I730035O10 (M13F)). 
 pCMV5 (with deleted PstI, Sal I restriction sites) was obtained from Hans 
Thoenen’s Lab (Joseph et al. 1990). 
 HN10e hippocampal cell line (Lee et al. 1990), from Yves-Alain Barde’s lab. 
 mturq2-CBD28k construct was provided by Alex Scheiter (fellow graduate 
student): CBD28k-TSGTGSGAT-mTurquoise2 (58 kDa) in pcDNA3.1 vector 
(Mammalian expression vector w/ CMV promoter and Ampicillin resistance 
gene) 
(B) Software: 
 SerialCloner (v2.61). BioEdit (v7.2.5). Jmol (v14.6.3_2016.09.18). SnapGene 
Viewer (v2.8.3). NEB TM calculator (≤v1.9.4). Science Gateway Protein Molecular 
Weight Calculator [http://www.sciencegateway.org/tools/proteinmw.htm]. 
NCBI BLAST [http://blast.ncbi.nlm.nih.gov]. ImageJ (v1.49). PixFRET (v1.50). MS 
Office 2016. IBM SPSS Statistics 21. GraphPad Prism 7. a|e - UV-Vis-IR Spectral 
Software (v2.2). Adobe Photoshop and Illustrator CC 2014. ScientiFig (v2.99). 
Template-based protein structure modeling was created using RaptorX web 
server (Källberg et al. 2012, Ma et al. 2013-b). PSSpred (Protein Secondary 
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Structure PREDiction) (Yan et al. 2013). PSIPRED secondary structure prediction 
method (Buchan et al. 2013, Jones 1999). 
 (C) Buffers and Solutions 
Buffers, solutions and chemicals were prepared according to Sambrook & Russel 2001, 
if not otherwise stated. Chemicals were analytical grade, from Sigma, if not otherwise 
stated. 
(Joseph Sambrook and David W. Russell, Molecular Cloning - A Laboratory Manual Cold 
Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2001, Appendix 1) 
 Radioimmunoprecipitation assay buffer (RIPA) lysis buffer: 150 mM NaCl, 1 % 
NP-40, 0.5 % Na-Deoxycholat, 0.1 % SDS, 50 mM Tris pH 8.0. 
 MOWIOL embedding medium: 25 ml water, 6 ml 1 M Tris pH 8.5, 6 g MOWIOL 
(Fluka, 81381), 18.9 g glycerol. 
 10x Orange G loading buffer (NEB). 
(D) Chemicals 
Chemicals were of analytical grade, from Sigma, if not otherwise stated. 
 Staurosporine (S4400, Sigma). 
 Ionomycin (I9657, Sigma). 
 DMSO (D8418, Sigma). 
 PBS for cell culture: DPBS (Dulbecco's PBS, Gibco, 14200-059, devoid of calcium 
and magnesium). 
 LB Medium and LB Agar (Roth). 
 Culture medium: 450 ml Dulbecco’s MEM, 50 ml heat-inactivated FBS (10 % 
fetal calf serum), 5 ml PS (1 %) (Penicillin, Streptomycin); sterile filtration; cold 
storage. 
o Penicillin-Streptomycin (P11-010, 10000 U/ml Penicillin G,10000 µg/ml 
Streptomycin, PAA/GE Healthcare). 
o DMEM (Dulbecco’s Modified Eagle’s Medium, GlutaMax, 4,5 g/l Glucose, 
61965-026, Gibco). 
o FBS (Fetal Bovine Serum) (S0115, tested for mycoplasma, viruses, 
Biochrom AG). 
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 Cryo freezing medium (culture medium, DMSO (10 %); sterile filtration; cold 
storage at -20 °C). 
 Trypsin-EDTA (0.25 % Trypsin, 1 mM EDTA, 25200-072, Gibco). 
 MACSfectin reagent (Miltenyi Biotec). 
 Water for cell culture and molecular biology (except gel electrophoresis). Aqua 
Braun (distilled, endotoxin-free, sterile, B. Braun). Millipore water. 
 Skimmed milk powder (Heirler Cenovis GmbH). 
 Nucleobond PC500 (Plasmid-Midi/Maxi-Prep, Machery-Nagel). 
 Protein Quantification Kit, BC Assay (Interchim). 
 (E) Antibodies (AB) for Western Blots 
 Secondary AB 
o ECL anti-rabbit IgG Horseradish Peroxidase coupled (GE Healthcare). 
 Primary ABs 
o RFP: 600-401-379, polyclonal (rabbit) (Biomol). 
o αGFP: AB3080, polyclonal (rabbit) (Millipore). 
o Calbindin-D28k: Cb38a, polyclonal (rabbit) (SWANT). 
o Caspase-3: 8G10, monoclonal (rabbit) (Cell Signaling). 
(F) Other Materials 
 General 
o Eppendorf Safe-Lock tubes (Eppendorf). 
o Pipette tips (sterile, RNAase-free, DNAse-free, DNA-free, pyrogen-free, 
Starlab). 
 Cell culture and microscopy 
o Microscope Coverslips (12 mm diameter, #CB00120RA1, Menzel/Thermo 
Fisher). Microscope slides (#02-1203, Menzel/Thermo Fisher). 
o Cell culture dishes and Centrifuge tubes (Greiner Cellstar). 
o Nalgene Rapid-Flow Sterile Disposable Filter Units (500 ml, aPES 
membrane, #569-0020, Thermo Fisher). 
 Molecular biology and protein biochemistry 
o Amersham Hybond blotting membrane (0.2 µm, PVDF, Sigma). 
o Rotilab blotting paper (1.5 mm, #CL75.1, Roth). 
o Spectra Multicolor Broad Range Protein Ladder (Thermo Fisher). 
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o PCR tubes (ABgene). 
o Various restriction endonucleases and CutSmart Buffer (NEB). 
o 2-log DNA ladder (NEB). 
o Phusion High-Fidelity DNA Polymerase (NEB). 
o T4 DNA Ligase-Kit (NEB).  
o 5-alpha competent Escherichia coli (NEB). 
o Nucleospin Extract II-Kit (Macherey Nagel). 
o SERVA Agarose (Serva GmbH). 
(G) Laboratory devices 
 General 
o Pipettes (2, 20, 200, 1000 µl, Gilson). 
o LABOPORT Diaphragm Vacuum Pumps (NB6 KN.18, Neuberger). 
o Various water baths. Rotilabo Block Heater H250 (Roth). 
o LSM710 confocal microscope (ZEN software, ZEISS). 
 Cell Culture 
o Sterile workbenches (Berner B-MaxPro-160). 
o Thermoshake Incubator Shaker (C. Gerhardt Analytical Systems). 
o Microscope DMI (Leica). 
o Incubator New Brunswick Galaxy 170S (Eppendorf). 
o Eppendorf 5804 Series Centrifuge (Eppendorf). 
o Neubauer counting chamber. 
 Molecular biology, protein biochemistry 
o Epoch Microplate Spectrophotometer (Take 3 plate, Gene 5 software, 
BioTec). 
o Minigel System Mini-PROTEAN 3 (Comb 1.5 mm, Bio-Rad). 
o Blotting device, semi-dry (self-constructed, Max-Planck-Institute of 
Neurobiology, Martinsried). 
o Powersupply: Desatronic 500/500 und Pharmacia LKB GPS 200/400. 
o Centrifuge: Biofuge Pico (Heraeus) und Eppendorf 5415 R (Eppendorf). 
o Mastercycler gradient (Eppendorf). 
o ChemiDoc Imaging System (Image Lab Software, Bio-Rad). 
o Gel Doc (Quantity One 4.4.0 software, Bio-Rad).  
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2.1. Molecular biology 
2.1.1. pCMV5 vector plasmid 
Vector plasmids are commonly used vehicles to insert foreign DNA fragments into cells. 
Among the basic characteristics of vector plasmids are an origin of replication, a multiple 
cloning site (MCS), a polyadenylation site and a selective genetic marker, providing 
resistance to an antibiotic agent. 
pCMV plasmids are mammalian expression vectors created by the Department of 
Molecular Genetics, University of Texas Southwestern Medical Center (Andersson et al. 
1989). The pCMV5 plasmid (4.7 kb) was acquired from Hans Thoenen’s Lab. Restriction 
enzyme digestion and DNA sequencing were performed for verification. This pCMV5 
vector features a pBR22 and bacteriophage f1 origin of replication (ori), an Ampicillin 
resistance gene, a SV40 origin, a human growth hormone fragment (hGH) that includes 
polyadenylation and transcription termination signals, a CMV promoter and a multiple 
cloning site that contains unique restriction sites for EcoR1, Bgl2, Kpn1, Miu1, Cla1, Hind3, 
Xba1, BamH1, XmaI and Sma1 (see table 4). For further details, see Suppl.: pCMV5 vector 
plasmid. 
 
  
Table 4. Restriction enzymes incompatible with target proteins. 
RE mAmetrine* CBD28k CASP3 tdTomato pIMPase* 
EcoRI (920)  X X   
Bgl2 (926)  X    
Kpn1(932) X     
MluI (938) X     
ClaI(944)      
Hind3 (950)      
XbaI (974)      
BamH1 (980)      
XmaI (984)      
SmaI (984)      
 
Note: 
[*with linker sequence] [X=cutting the specified sequence] 
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2.1.2. Primer design and Polymerase Chain Reaction (PCR) 
Polymerase Chain Reaction (PCR) is a standard laboratory procedure used for 
exponential amplification of specific DNA sequences. Utilizing thermostable DNA 
polymerases, specific DNA is exponentially amplified by reiterated cycles of 
denaturation (~ 95 °C), annealing (~ 50 - 72 °C) and elongation (~ 72 °C). 
All PCR reactions were performed with a thermostable polymerase (Phusion High-
Fidelity DNA Polymerase, NEB), based on an enhanced Pyrococcus-like fusion enzyme. 
Forward and reverse primer pairs were designed in BioEdit for N-terminal fusion 
proteins. Virtual PCRs were simulated in SerialCloner. Designed primers were ordered 
from biomers.net GmbH and processed according to the supplied protocol. PCRs were 
performed with respective settings calculated by NEB TM calculator. 
2.1.2.1. mAmetrine primers 
Complete forward primer (EcoR1):  
5'-GAC-TAT-gaattc-GCC-ACC-ATG-GTG-AGC-AAG-3' 
Complete reverse primer (Hind3):  
5'-TAG-ATC-aagctt-TCC-ACT-GCC-ACT-GCC-GGT-3' 
NEB TM calculator [Phusion High-Fidelity DNA Polymerase (HF Buffer], 500 nM) 
 PCR Annealing Temp.: Complete Primer 72 °C / Gene-specific 66 °C 
 Forward primer: Complete Primer 76 °C / Gene-specific 66 °C 
 Reverse primer: Complete Primer 79 °C / Gene-specific 71 °C 
A detailed documentation of the primer design can be found in Suppl.: mAmetrine 
forward and reverse primer. 
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2.1.2.2. Calbindin-D28k primers 
Complete forward primer (Hind3):  
5'-TAA-GTA-aagctt-ACT-ACG-ATG-GCA-GAA-TCC-3' 
Complete reverse primer (BamH1):  
5'-TAA-GTA-ggatcc-CTA-GTT-GTC-TCC-AGC-AGA-3' 
NEB TM calculator [Phusion High-Fidelity DNA Polymerase (HF Buffer], 500 nM) 
 PCR Annealing Temp.: Complete Primer 70 °C / Gene-specific 54 °C 
 Forward primer: Complete Primer 67 °C / Gene-specific 58 ° C 
 Reverse primer: Complete Primer 70 °C / Gene-specific 54 ° C 
A detailed documentation of the primer design can be found in Suppl.: CBD28k forward 
and reverse primer. 
2.1.2.3. tdTomato primers 
Complete forward primer (EcoR1):  
5'-TAT-GTA-gaattc-GAT-GGT-ATG-GTG-AGC-AAG-3' 
Complete reverse primer (Kpn1):  
5'-CAC-CTA-ggtacc-CTT-GTA-CAG-CTC-GTC-CAT-3' 
NEB TM calculator [Phusion High-Fidelity DNA Polymerase (HF Buffer], 500 nM) 
 Annealing Temp.: Complete Primer 72 °C / Gene-specific 53 °C 
 Forward primer: Complete Primer 70 °C / Gene-specific 56° C 
 Reverse primer: Complete Primer 73 °C / Gene-specific 53 °C 
A detailed documentation of the primer design can be found in Suppl.: tdTomato 
forward and reverse primer. 
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2.1.2.4. Caspase-3 primers 
Complete forward primer (Kpn1):  
5'- GGT-CGT-ggtacc-ACC-ATG-GAG-AAC-AAC-AAA-3' 
Complete reverse primer (Cla1):  
5'-GCG-GGC-atcgat-CTA-GTG-ATA-AAA-GTA-CAG-3' 
NEB TM calculator [Phusion High-Fidelity DNA Polymerase (HF Buffer], 500 nM) 
 Annealing Temp.: Complete Primer 72 °C / Gene-specific 40 °C 
 Forward primer: Complete Primer 77 °C / Gene-specific 56 °C 
 Reverse primer: Complete Primer 72 °C / Gene-specific 40 °C 
A detailed documentation of the primer design can be found in Suppl.: CASP3 forward 
and reverse primer. 
2.1.2.5. Partial IMPase primers 
Oligonucleotide primer pair: 
5'-gta-tta-ggt-acc-gga-agt-gga-agc-
ggc-agc-ggc-agc-ggc-agc-acc-ggc-ctg-
gtg-acc-gtg-acc-gac-cag-aag-gtg-gag-
aag-atg-ctg-3' 
5'-gcg-cta-atc-gat-tta-tca-ctc-ctc-gcc-
gat-gaa-gct-gtg-gca-ggg-gta-ctt-ctc-
ctt-gat-gct-gct-cat-cag-cat-ctt-ctc-cac-
ctt-ctg-gtc-3' 
 Primers were hybridized to yield partially overlapping double strand 
 5 cycles to extend the 3’ ends 
 Annealing Temp.: 68 °C 
  
 
 
Figure 12. pIMPase PCR. 
PCR was performed without template. 5 cycles extending 
the 3’ ends, where followed by amplification of the PCR 
product with 2 amplification primers. 
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Amplification forward primer (Kpn1): 
5'-GTA-TTA-ggt-acc-GGA-AGT-GGA-3' 
Amplification reverse primer (Cla1): 
5'-GCG-CTA-atc-gat-TTA-TCA-CTC-3' 
 30 cycles 
 Annealing Temp.: 61 °C 
PCR was performed as illustrated in figure 12. A detailed documentation of the primer 
design can be found in Suppl.: IMPase design and construction.  
2.1.3. Restriction enzyme (RE) digestion 
Restriction endonucleases, commonly used as molecular cutting tools, are proteins that 
are capable of detecting and cutting specific DNA sequences. After detection of a 
specific restriction site, REs cut DNA leaving either sticky or blunt ends. 
Vector plasmids and the PCR products were processed with respective matching REs, 
so that resulting fragments could be inserted into linearized vector plasmids. After 
mixing DNA samples with REs and the respective buffers, samples were usually 
(shortly) centrifuged and incubated at 37 °C for approximately 1 hour in a block heater. 
2.1.4. Gel electrophoresis (GE) 
Gel electrophoresis (GE) is a standard laboratory procedure for separating DNA 
molecules by size. Making use of its negative charge, DNA moves towards the anode 
through pores of the agarose gel in an electrical field. Speed is strongly dependent on 
size and conformation of the respective fragments. When labelled with ethidium 
bromide, an intercalating agent used for DNA detection, DNA becomes visible under UV 
light.  
Analytical and preparative gels were prepared with SERVA-Agarose (Agarose (1 %) 
gels). Agarose powder was mixed with Tris-acetate-EDTA (TAE) buffer and then heated 
in a microwave. Afterwards, ethidium bromide was added. The mixture was then 
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poured into the GE-chamber (with a suitable comb) and could gel for about 20 - 30 
minutes. DNA samples were mixed with a loading buffer (w/ tracking dye), to increase 
density and visibility of the sample. At last, a 2-log DNA ladder and DNA samples were 
loaded. GEs were usually performed at 75 V/68 mA for 45 minutes. 
GE was primarily used for verification of PCR products by size of the amplificate, 
isolation of fragments or for the purpose of verification of plasmids in analytic digests. 
Gels were then visualized and documented. 
2.1.5. Ligation of DNA 
Ligations were used to insert DNA fragments into linearized vector (pCMV5) backbones. 
Eluates obtained from purification (see chapter 2.1.6), were ligated using a T4 DNA 
Ligase kit (NEB). The average DNA concentrations were determined using a 
spectrophotometer. A control sample without DNA insert was prepared as well as a 
ligation sample with 1:3 and 1:6 molar ratio of DNA insert and vector. Incubation was 
carried out at room temperature for 10 minutes (for sticky ends). Heat inactivation was 
done at 65 °C (where applicable) for 10 minutes, followed by chill on ice and subsequent 
transformation (see chapter 2.2.1). 
2.1.6. Purification of DNA 
Purifications were performed after isolating bands from agarose gels. Dyed fragments 
were cut out from the gel under UV light control and were then purified by binding DNA 
to a silica membrane prior to elution (Nucleospin Extract II-Kit, Macherey-Nagel). 
2.1.7. DNA sequencing 
DNA sequencing was performed by Eurofins Genomics GmbH using the dideoxy-chain 
termination method (Sanger et al. 1977). For verification, the reports were then 
compared with the respective anticipated sequence. 
2.1.8. SDS-Page and Western Blot 
Western blot is an analytical method for specific protein detection (Towbin et al. 1979). 
Using protein-specific antibodies, proteins within a cellular lysate are stained on a 
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membrane. Western Blots were primarily used for fusions construct verification and 
assay of protein expression. 
Cells were lysed with RIPA buffer (0.5 ml/6 cm dish). Cell culture plates on ice were 
carefully shaken on a swivel plate for 30 minutes. Loaded into a tube, the mixture was 
centrifuged for 10 minutes at 10000 g and 4 °C. Afterwards, the pellet was stored and 
the protein concentration of the supernatant was determined using a 
spectrophotometer. Proteins were then separated by sodium dodecyl sulfate (SDS) 
polyacrylamide gel electrophoresis (PAGE) as described in Sambrook & Russel (2001). 
Protein samples (20 µg in 20 µl) were mixed with 5 µl 1 M dithiothreitol (DTT) and 8 µl 
SDS-Page loading buffer. The mixture was shortly centrifuged, heated to 95 °C for  
5 minutes for denaturation and then cooled at room temperature. A protein ladder with 
pre-stained chromophore-labeled proteins, was used for the determination of 
molecular weight. Prior to electrophoresis, SDS was pre-heated to 37 °C to prevent 
precipitation. Electrophoresis was then performed at 100 V for approximately 30 
minutes, then at 200 V for another 45 minutes.  
Proteins were transferred to a membrane using transfer cassettes assembled from 2x 
blotting paper, PVDF membrane, SDS-PAGE gel and 2x blotting paper. Beforehand, 
components of the transfer cassette were primed for usage: incubation of the gel in 
transfer buffer for 15 minutes (on a swivel plate); immersion of the blotting paper in 
transfer buffer and the membrane in methanol for 10 seconds, then water for 5 minutes 
and at last in transfer buffer. Transfer cassettes were inserted into the loaded semi-dry 
blotter and blotting was performed for 1 hour at 260 mA. Afterwards, the membrane 
was washed in (deionized) water for 5 minutes, which was followed by reversible 
Ponceau S staining to assess the transfer efficiency. Then, the membrane was washed 
in blotting buffer and subsequently immersed in the block buffer (Dried milk powder (5 
%), Tween (0.2 %) 20 in phosphate buffered saline (PBS)) for 1 hour to prevent non-
specific binding. The first antibody (in 5 ml blotting buffer; at the dilution specified 
below) was applied and incubated overnight at 4 °C on the swivel plate. After 
application of the first antibody, the membrane was thoroughly washed in washing 
buffer and the secondary antibody, conjugated with peroxidase (details below), was 
added at the appropriate dilution and incubated in washing buffer for 1 hour at room 
temperature. After incubation with detection reagent, the membrane was washed in 
washing buffer and, subsequently, imaged and documented. 
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 Western Blot of mAmetrine-CBD28k with CBD28k-antibody:  
Antibody: Cb38 (1:10000). 2. Antibody: α rabbit peroxidase (1:10000) 
 Western Blot of mAmetrine-CBD28k with GFP-antibody: 
Antibody: αGFP (1:2000). 2. Antibody: α rabbit peroxidase (1:10000) 
 Western Blot of tdTomato-CASP3 with Caspase-3-antibody: 
Antibody: Caspase-3 (1:1000). 2. Antibody: anti rabbit peroxidase (1:10000) 
 Western Blot of tdTomato-CASP3 with RFP-antibody: 
Antibody: RFP (1:2000). 2. Antibody: α rabbit peroxidase (1:10000) 
Note: 
 each lane with ~ 20 µg in 22 µl 
 Calbindin-D28k: D505.11 (mouse cerebellar lysate), 10 µg 
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2.2. Cellular biology 
2.2.1. Transformation 
Transformation describes the transfer of exogenous genetic material into bacterial cells. 
Vectors were transformed into 5-alpha competent Escherichia coli according to the 
manufacturer’s High Efficiency Transformation Protocol. 
5-alpha competent Escherichia coli (NEB), stored at -80 °C in dry ice, were thawed on 
ice for 10 minutes. 5 µl with 100 ng of plasmid DNA were added, gently mixed and then 
put on ice for 30 minutes. A heat shock (90 seconds at 42 °C) was applied, which was 
followed by 5 minutes on ice. 950 µl (room temperature) SOC were added to the tube, 
which was then incubated in a bacterial incubator shaker for 45 minutes at 37 °C for 
optimal cell recovery and antibiotic resistance expression. Afterwards, 100 µl of each 
sample (1:3 and 1:6 molar ratios, digested and intact vector, ligation control sample) 
was evenly spread onto a pre-warmed (37 °C) Ampicillin selection plate. Finally, the 
selection plates were incubated at 37 °C for 12 - 24 hours. 
2.2.2. Isolation and expansion of clones 
Clones were carefully picked from the incubated selection plates and suspended in a 
mixture of 5 ml LB-medium and 100 µg/ml Ampicillin. Then, the cell mixture was 
incubated overnight at 37 °C in a bacterial incubator shaker. 
2.2.3. Plasmid preparation 
DNA-Mini- and DNA-Maxi-Preps are commonly used methods to extract and purify 
plasmid DNA. Maxi-Preps were carried out using anion-exchange chromatography, 
according to the manufacturer’s specifications (Nucleobond PC500, Machery-Nagel). 
DNA-Mini-Prep: 1.5 ml of bacterial culture was added into a tube. The tube was 
centrifuged for 10 minutes at 12000 g. While supernatant was carefully removed, the 
pellet was resuspended with a resuspension buffer. Then, an alkaline lysis buffer was 
added to the sample to induce cell lysis. This was followed by a neutralization buffer. 
Afterwards, the sample was centrifuged at 12000 g to clarify the lysate. For 
precipitation, 300 µl of the supernatant were added to 300 µl isopropyl alcohol. Each 
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sample was then mixed, incubated for 5 minutes at room temperature and centrifuged 
at 12000 g for 10 minutes. Following, supernatants were carefully removed, pellets 
were washed with ethanol (70 %) and centrifuged for 1 minute at 12000 g. Again, 
supernatant fluid was removed and pellets were dried at 37 °C, and in a final step 
resuspended in 5 µl RNAase-free water. Afterwards, a restriction enzyme digestion was 
carried out for verification.  
2.2.4. Preparation of eukaryotic cell lines 
All experiments were carried out with the murine hippocampal HN10e cell line. 
Revitalization/Thawing of HN10e cells 
A falcon tube (6 ml) and a culture dish (8 ml) were filled with pre-warmed (37 °C) 
culture medium. Cryopreserved cells were warmed up to 37 °C in a water bath and 
transferred into the falcon tube for dilution of the potentially cell damaging cryo freezing 
medium. Then, the tube was centrifuged at 300 g for 5 minutes. After removal of 
supernatant fluid, pelleted cells were resuspended with 2 ml of culture medium, 
transferred onto the culture dish and finally incubated at 37 °C and 10 % CO2 in air for 
the period required. 
Cell passage 
After aspiration of culture medium, a washing step with either 2 - 5 ml of PBS + 1 mM 
EDTA solution or Trypsin (0.25 %) solution was carried out. This was followed by 
aspiration of residual fluids and addition of 1 ml Trypsin (0.25 %) to detach cells. Plates 
were then incubated at 37 °C and 10 % CO2 in air for up to 10 minutes if required. For 
dilution and inhibition of trypsin, the cell mixture was added into a falcon tube with  
2 - 5 ml culture medium. Subsequently, falcon tubes were centrifuged at 300 g for 5 
minutes. Supernatant fluid was carefully removed and cells were resuspended with  
2 - 4 ml of culture medium. Cells were then allocated on culture dishes in culture 
medium and finally incubated at 37 °C and 10 % CO2 in air as required. 
Preparation of cells for experiments 
After cell passage, cells were counted in a counting chamber and plated at the desired 
subconfluent densities. 
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Preparation of cells for Western Blot 
After cell passage, cells were plated on 6 cm cell culture dishes in culture medium of 
the subconfluent densities detailed in the protocol of the transfection kit (see chapter 
2.2.5.) and prepared for Western Blot according to protocol. 
Preparation of cells for indirect immunofluorescence 
After cell passage, allocation of approximately 20000 cells/100 µl onto each CS (3 CS 
per each 3 cm dish). Incubation at 37 °C and 10 % CO2 in air for approximately 2 hours. 
Culture dishes were finally filled with 1.5 ml culture medium. If needed, cells were 
treated with cytotoxic agents (see chapter 2.2.6.). 
2.2.5. Transient transfection 
Transfection describes the transfer of exogenous genetic material into eukaryotic cells. 
Transient transfections were performed to insert vector plasmids into the murine 
hippocampal HN10e cell line. All transfections were carried out according to protocol 
using a transfection kit (MACSfectin reagent, Miltenyi Biotec) based on cationic 
lipopolyamines.  
Standard transfections were performed with 6 or 12 µg of total DNA per 6 or 10 cm 
dish, respectively, on 60 - 80% subconfluent cells (equal amount of each DNA in case 
of double transfections). Transfection efficiencies were between 50 - 70%. 
After separately diluting DNA and reagent in DMEM (without additions), both samples 
were briefly mixed and incubated at room temperature for 20 minutes to allow complex 
formation. After drop-wise addition of transfection complexes, cells were incubated 
under standard conditions for 1 – 3 days. 
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2.2.6. Application of cytotoxic agents 
Dimethyl sulfoxide (DMSO) 
Dimethyl sulfoxide is a commonly used aprotic solvent for polar and nonpolar 
molecules. 
However, it is known that DMSO causes cytotoxic plasma membrane pore formation at 
low concentration of 10 %. Interestingly, even at very low concentrations of 2 – 4 %, 
DMSO seems to be able to induce Caspase-3 independent cell death in neuronal cell 
lines (Galvao et al. 2014). 
Ionomycin (INM) 
Ionomycin is a Ca2+-ionophore, which is produced by the bacterium Streptomyces 
conglobatus.  It is widely used as a research tool to induce Caspase-3-mediated cell 
death, raise intracellular calcium levels and stimulate an inflammatory response by 
expressing cytokines (Liu & Hermann 1978). 
Treatment with INM was performed with 2 µM for 24 hours (see 1.4.2.). 
Staurosporine (STS) 
Staurosporine, which was isolated from the bacterium Streptomyces staurosporeus, is 
an ATP-competitive kinase inhibitor, which is capable of inducing caspase activation a 
few hours after its application (Nakano 2009). 
Treatment with STS was performed with either 10 µM for 11 hours or 15 µM for 4 hours 
(see 1.4.1.). 
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2.2.7. Preparation of slides for confocal microscopy 
Preparation of coverslips (CS) 
After cleansing with ethanol (100 %), 3 CS were placed on each 30 mm cell culture dish. 
All dish plates were washed with distilled water to remove residual ethanol. Following 
aspiration, CS were left to dry at room temperature. 100 µl of Poly-L-Lysine (average 
molecular weight 70 kDa; 0.01 %) (PLL) was added to each CS. Dishes were then 
incubated at 37 °C and 10 % CO2 in air for at least 1 hour. After aspiration of residual 
PLL, 3 more washing steps with distilled water were carried out and CS were 
subsequently dried. 
Preparation of slides 
Cells were transfected (see chapter 2.2.5.) and transferred to CSs (see chapter 2.2.4.). 
After aspiration of culture medium, a washing step with 1 ml PBS was performed. Cells 
were fixated with 1 ml PFA (4 %) at room temperature for 15 minutes. This was followed 
by 3 more washing steps with PBS (last washing step excludes the aspiration of PBS). 
CS were mounted in 6 µl Mowiol (warmed in a water bath at 37 °C) on standard 
microscopy slides. After removal of residual fluid, 3 CSs were transferred onto each 
slide with the CS’s surface facing the slide’s surface. Pressure was softly applied to 
reassure direct contact between CSs and slide. Slides were then stored in a light-free 
environment at room temperature for 12 - 72 hours. During imaging, CS were usually 
kept at room temperature for approximately 6 - 10 hours. 
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2.3. Confocal-Imaging 
All cells were assayed with the ZEISS LSM710 confocal microscope. Before confocal 
imaging, samples were analyzed for general vitality and brightness under 
epifluorescence (both GFP and DsRed Preset with 60x magnification).  
It is known that unfavorable stoichiometry beyond 10:1 or 1:10 can limit the validity of 
intermolecular FRET-measurements (Berney & Danuser 2003, Chen et al. 2006). Based 
on samples transfected with the intramolecular FRET biosensor and, therefore, with 1:1 
ratio, an Acceptor-to-Donor ratio (mean ADR = 1.78; n = 10;) was calculated from the 
respective absolute intensities. Consequently, an ADR-range of 0.16 - 3.4 (mean ± 4.5-
fold standard deviation) was determined and defined as sample selection criteria to 
avoid substantial unfavorable stoichiometry. Samples beyond this range were 
discarded. 
In intermolecular FRET experiments, each sample was sequentially analyzed by 
Sensitized Emission, then Photobleaching, for the purpose of inter-methodological 
comparison of FRET-efficiency. Therefore, it was necessary to keep imaging-induced 
bleaching to a minimum. The bleaching step was performed early on after 1/5 scans 
and the total number of images acquired for SE was limited to 2 scans. Screening under 
epifluorescence was carried out with low lamp power to reduce potential photo-
bleaching. Moreover, laser transmission power and scan speed settings were optimized. 
Gain settings were kept low to reduce noise and allow overhead in the dynamic range. 
The final imaging-configuration was determined after extensive pilot experiments. 
Within each experiment, all samples were assayed with the same settings.  
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2.3.1. Imaging-Configuration 
Acceptor-Photobleaching 
 Image size: x: 256, y: 256 / time: 5 / channels: 2 / 16-bit / Dimension: x: 33.61 µm, Y: 33.61 µm /  
Zoom: 4.0 / pixel dwell time: 5.09 µs / average: 1 
 tdTomato-channel: Master Gain: 700 / 561 nm laser at 0.1 % / Pinhole 49 µm | 0.78 Airy Units |  
0.8 µm section / Digital Offset: 0 / Digital Gain: 1 
 mAmetrine-channel: Master Gain: 675 / 405 nm Laser at 1 % / Pinhole 49 µm | 0.99 Airy Units |  
0.7 µm section / Digital Offset: 0 / Digital Gain: 1 
 Bleach event after 1/5 images at 561 nm with 55 % laser transmission 
 Objective: Plan-Apochromat 63x/1.40 Oil DIC M27 / Detector settings: 499 - 537 
 Beam splitters: MBS: MBS 458/561 / MBS_InVis: MBS -405 / DBS1: Mirror / FW1: NoneLSM 
 Scan mode plane, time series 
mTurquoise2 quantification 
 Image size: x: 256, y: 256 / time: 2 / channels: 1 / 16-bit / Dimension: x: 33.61 µm, Y: 33.61 µm / 
Zoom: 4.0 / pixel dwell time: 5.09 µs / average: 1 
 mTurquoise2-channel: Master Gain: 600 / 405 nm laser at 1 % / Pinhole 45 µm | 1 Airy Units |  
0.7 µm section / Digital Offset: 0 / Digital Gain: 1 
 Objective: Plan-Apochromat 63x/1.40 Oil DIC M27 / Detector settings: 455 - 499 
 Beam splitters: MBS: MBS 458/561 / MBS_InVis: MBS -405 / DBS1: Mirror / FW1: NoneLSM 
 Scan mode plane, time series 
Sensitized Emission 
 Image size: x: 256, y: 256 / time: 2 / channels: 2 / 16-bit / Dimension: x: 33.61 µm, Y: 33.61 µm /  
Zoom: 4.0 / pixel dwell time: 5.09 µs / average: 1 
 Multitrack configuration: Pinhole 49 µm | 0.99 Airy Units | 0.7 µm section 
 tdTomato-channel: Master Gain: 700 / 561 nm laser at 0.1 % / Digital Offset: 0 / Digital Gain: 1 
 mAmetrine-channel: Master Gain: 675 / 405 nm Laser at 1 % / Digital Offset: 0 / Digital Gain: 1 
 Objective: Plan-Apochromat 63x/1.40 Oil DIC M27 / Detector settings: Ch1: 499 - 537, Ch2: 602 - 693 
 Beam splitters: MBS: MBS 458/561 / MBS_InVis: MBS -405 / DBS1: Mirror / FW1: NoneLSM 
 Scan mode plane, time series 
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2.3.2. Data acquisition and analysis 
In theory, one would assume spectral bleed-through (SBT) ratios to remain constant. 
However, it was demonstrated that these values can vary substantially dependent on 
the absolute intensity measured on confocal microscopes with more than one 
photomultiplier for detection of donor and acceptor channel (Feige et al. 2005). 
Matching SBT ratios to measured FRET-sample intensities is an alternate approach to 
linear or exponential SBT models that can provide FRET calculations with higher 
accuracy, particularly when FP concentration varies strongly and low FRET-efficiencies 
are expected (Feige et al. 2005). For less false positive results, SBT correction factors 
for each (arbitrarily designated) intensity group (4000 - 9999, 10000 - 14999, 15000 - 
19999, 20000 - 25000) were defined as sum of the average SBT correction factor and 
its standard deviation. For these experiments, measurements with absolute intensities 
< 4 x 103 and > 25 x 103 (on a 16-bit scale) were discarded to avoid samples with 
substantial overexpression, which can potentially result in non-physiological effects, 
and, additionally, prevent growing impact of artefacts on the calculated FRET-efficiency 
at lower absolute intensities. SBT correction factors were determined for the donor 
construct and the CASP3 acceptor construct. For validation, the SBT correction factors 
were also calculated for the respective unconjugated FPs, which showed similar results. 
Therefore, SBT correction factors from the FP-conjugated constructs were applied for 
all nFRET calculations. In Caspase-3 activity experiments, both ADR-range and absolute 
intensity thresholds (for rejection) were not established. 
The obtained data was analyzed in Microsoft Excel 2010 with the respective formulas 
(see chapter 1.3.2.). Background subtraction (variable ROI without cellular overlap) was 
carried out on all images. Region of interest (ROI) for analysis and bleaching was defined 
as the cell soma. On selected cells, a pixel-by-pixel analysis using ImageJ and PixFRET 
was performed to investigate compartmental FRET (Feige et al. 2005). For analysis in 
PixFRET, slice 1 was selected for analysis. The images were processed with a Gaussian 
blur of 1.5 to reduce noise and improve rendering of the computed image. Intensity-
matched SBT correction factors were defined as constants. Threshold correction factor 
was set to 2 and normalization by the square root of the product of donor and acceptor 
intensities was selected. nFRET images were stored as 32-bit TIF files. For the purpose 
of illustration, Rainbow2 Look Up Table (LUT) was additionally applied. 
42 
All statistical analysis was performed in IBM SPSS Statistics 21 or GraphPad Prism 7.  
Homogeneity of variance was tested using Brown-Forsythe test (reported where 
violation of homogeneity occurred). All comparisons performed were planned and were 
reported.  Significance was assessed using either Student’s unpaired t-test or Mann-
Whitney U test for two-group comparisons or one-way ANOVA (with either 
Bonferroni’s or Dunnett's multiple comparison test) for more than two-group 
comparison with nearly equal sample size or Kruskal-Wallis test (with Dunn’s post hoc 
test) with a 95 % confidence interval (* = p < 0.05, ** = p < 0.01, *** = p < 0.001). 
2.4. Miscellaneous 
GraphPad Prism 7, Adobe® Photoshop CC, Adobe® Illustrator CC and ScientiFig were 
used to create scientific illustrations (Aigouy & Mirouse 2013). a|e - UV-Vis-IR Spectral 
Software was used for the visualization of spectral properties. 
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3. Results 
3.1. Fusion proteins 
3.1.1. FRET donor: mAmetrine-CBD28k 
The amino-/N-terminal fusion protein was constructed within the MCS of a pCMV5 
vector plasmid consisting both of mAmetrine (without Stop-Codon) and CBD28k (with 
Stop-Codon) (see figure 13). Both components were bridged by a flexible linker 
sequence (GTGSGSG-KLTT). The sequenced construct can be seen in Suppl.: mAmetrine 
(incl. linker and without TAA stop codon) + EcoR1 + CBDK28k (incl. stop codon) inserted 
in pCMV5 multiple cloning site. Protein expression was confirmed by Western Blot (see 
figure 14). Construct appeared functional in indirect immunofluorescence (data not 
shown). 
 
Figure 13. Structure prediction of mAmetrine-CBD28k (57 kDa). 
Some residues of CBD28k are not modeled due to lack of reasonable templates. RaptorX 
structure prediction displayed using Jmol and colored according to secondary structure. 
 
 
Figure 14. Western Blot of mAmetrine-CBD28k fusion construct. 
Samples on the left panel were probed with a CBD28k-AB. Samples on the right panel were probed with a GFP-AB.  
(1) mAmetrine-CBD28k, (2) tdTomato-pIMPase, (3) tdTomato-CASP3, (4) mAmetrine, (5) tdTomato, (6) mAmetrine-
DEVD-tdTomato, (7) Control, (8) CBD28k (mouse cerebellar lysate). 
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3.1.2. FRET acceptor: tdTomato-CASP3 
An amino-/N-terminal fusion protein was constructed within the MCS of a pCMV5 
vector plasmid consisting of tdTomato (without Stop-Codon) and Pro-Caspase-3 (with 
Stop-Codon) bridged by a linker sequence (GTT) built from small, uncharged amino 
acids for least interaction and high flexibility (Chen et al. 2013) (see figure 15). The 
sequenced construct can be found in Suppl.: TdTomato (without TAA stop codon) + 
Kpn1 + GTT-Linker + CASP3 (incl. stop codon) inserted in pCMV5 multiple cloning site. 
Protein expression was confirmed by Western Blot (see figure 16). Construct appeared 
functional in indirect immunofluorescence (data not shown). 
 
Figure 15. Structure prediction of tdTomato-CASP3 (76 kDa). 
RaptorX structure prediction displayed using Jmol and colored according to secondary structure. 
 
 
Figure 16. Western Blot of the tdTomato-CASP3 and tdTomato-pIMPase fusion constructs. 
Samples on the left panel were probed with a Caspase-3-AB. Samples on the right panel were probed with a RFP-AB. 
(1) mAmetrine-CBD28k, (2) tdTomato-pIMPase, (3) tdTomato-CASP3, (4) mAmetrine-DEVD-tdTomato, (5) mAmetrine, 
(6) tdTomato, (7) CBD28k (mouse cerebellar lysate). Bands at ~ 35 kDa show endogenous Caspase-3. 
 
 
Figure 17. Caspase-3 pro-domain within tdTomato-CASP3 construct. 
The suggested pro-domain interaction site of Homo sapiens and Mus musculus shows a similarity of 75 %. Similarity 
determined using NCBI BLAST. Asp X: Cleavage occurs after specific aspartate residues. 
45 
While large and small subunits of caspases usually share high sequence homology, 
the contrary applies to their pro-domains. Although initiator caspases feature long 
pro-domains of over 100 amino acids including specific interaction motifs, effector 
caspases, such as Caspase-3, characteristically have short pro-domains (~ 30 residues) 
(Chang & Yang 2000). As demonstrated in figure 17, a minor interspecies variation in 
target peptide sequence between the pro-domain of Homo sapiens and Mus 
musculus exists. 
3.1.3. FRET acceptor: tdTomato-pIMPase 
Earlier studies showed that the interaction site is 
a helix-associated 12 amino acid sequence 
(residues 55 – 66; MSSIKEKYPCHS) (Almog et al. 
2011). Based on predictions of IMPase’s secondary 
structure (see Suppl.: IMPase secondary 
structure), it was concluded that the residues 42 – 
71 (LVTVTDQKVEKML – MSSIKEKYPCHS - FIGEE) 
would make a helix formation probable (see figure 
18). Moreover, matching murine IMPase1 and CBD28k were selected to prevent inter-
species incompatibility as previously reported (Almog et al. 2011). 
 
An amino-/N-terminal fusion protein was constructed within the MCS of a pCMV5 
vector plasmid consisting both of tdTomato (without Stop-Codon) and a partial IMPase 
sequence (with Stop-Codon) bridged by a linker sequence (GTGTGSGSGSGSTG) (see 
 
Figure 18. Structure prediction of pIMPase.  
Seq.: LVTVTDQKVEKML-MSSIKEKYPCHS-FIGEE. 
RaptorX structure prediction displayed using 
Jmol and colored according to secondary 
structure. 
 
Figure 19. Structure prediction of tdTomato-pIMPase (59 kDa). 
Partial IMPase is not modeled due to lack of reasonable templates. RaptorX structure prediction 
displayed using Jmol and colored according to secondary structure. 
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figure 19). The sequenced construct can be found in Suppl.: tdTomato (without TAA 
stop codon) + Kpn1 + Linker + partial IMPase sequence (incl. stop codon) inserted in 
pCMV5 multiple cloning site. Protein expression was confirmed by Western Blot (see 
figure 16). Construct appeared functional in indirect immunofluorescence (data not 
shown). 
3.2. Pilot experiments 
Unattached mAmetrine and its fusion with CBD28k were predominantly localized in the 
cytosol und nucleus. Unconjugated tdTomato, tdTomato-CASP3 and the mAmetrine-
DEVD-tdTomato construct were mainly found in the cytosolic milieu and were excluded 
from the nucleus. 
3.2.1. Signal increase upon photobleaching 
Pilot experiments with tdTomato-CASP3-transfected cells showed that there is a signal 
increase in the mAmetrine-Channel upon photobleaching. While the signal increase 
occurred upon photobleaching (80 % laser transmission at bleaching event), it did not 
appear in a time series (30 images without bleaching event; each with 1 % laser 
transmission). The extent of signal increase appeared to correlate with the initial 
tdTomato intensity and the (bleaching) laser transmission power. Reducing 
photobleaching laser transmission (from 80 % to 55 %) resulted in decreased signal 
increase. A series of repetitive bleaching experiments showed that there was a gradual 
recovery (1.07- to 1.12-fold) of tdTomato signal after the photobleaching event. 
Moreover, a distinct homogenous green emitting signal, stronger than the 
autofluorescence of non-transfected cells, could be detected in tdTomato-CASP3 
expressing cells in epifluorescence (GFP filter). Signal increase upon photobleaching in 
the mAmetrine channel was corrected by subtraction of the estimated increase, 
determined by multiplying the absolute intensity in the tdTomato-Channel with a 
common corrective rate, which was obtained from tdTomato-CASP3-transfected 
control samples (20 samples). To prevent false positives and undercorrection, the final 
corrective rate was determined as sum of the mean rate and its standard deviation  
(3.4 % + 1.1 % = 4.5 %). In Caspase-3 activity experiments, signal increase upon 
photobleaching was determined as in the intermolecular FRET experiments using the 
SE imaging profile. Due to the absence of a lower and upper limit of absolute intensity 
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in these experiments, a minority of samples showed intensities beyond the dynamic 
range (after tdTomato excitation and tdTomato detection) and, consequently, 
displaying saturated pixels. For more accurate determination of the signal increase upon 
photobleaching, these samples were re-scanned with an attenuated gain setting of 
600. A group of independent measurements with both the original gain setting (of 700) 
and the adjusted gain setting (of 600) showed that the absolute intensity differed by 
the factor of 3. This gain adjustment was then compensated by multiplying the 
calculated corrective rate with the factor 3. 
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ΔIPOST Signal increase (mAmetrine channel) upon photobleaching 
IFP tdTomato emission after tdTomato excitation 
 
In addition, imaging settings and experimental setup were appropriately adjusted to 
account for these artefacts (see methods). 
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3.2.2. mTurquoise2 spectral bleed-through (SBT) 
While biosensor-transfected samples demonstrated insignificant SBT into the 
mTurquoise2 detection channel, mturq2-CBD28k-transfected samples displayed 
substantial bleed-through into the mAmetrine-Channel. For this purpose, mturq2-
CBB28K-transfected cells (10 samples) were analyzed to quantify SBT and mTurquoise2 
emission. On the basis of SBT and mTurquoise2 emission, an average bleed-through 
corrective factor (pre-bleach: 0.9411; post-bleach: 0.9348) was calculated. Comparison 
of the measured SBT values with the calculated values showed that this corrective 
approach is accurate and reliable (calculated pre-bleach error:  
0.1 % ± 1.6 %; calculated post-bleach error: -0.2 % ± 1.8 %).  
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CSBT SBT corrective factor for pre- and post-bleach 
SBT SBT into the mAmetrine-Channel 
IFP mTurquoise2 emission after mTurquoise2 excitation 
 
  
49 
3.2.3. In-situ assay of Caspase-3 activity upon expression of Calbindin-D28k 
In order to assess whether an effect on Caspase-3 activity can be detected using the 
available Caspase-3 biosensor upon increased expression of CBD28k, the following FRET 
pilot experiments (each n = 1) were performed with unconjugated and conjugated 
CBD28k.  
Unconjugated Calbindin-D28k 
 
 
 
 
 
 
 
 
 
 
 
 
A one-way analysis of variance (ANOVA) was used to compare the effect of CBD28k 
co-transfection on Caspase-3 activity among treatment (± STS) and apoptotic (± CD) 
conditions (see figure 20). There was a statistically significant difference between group 
means at the p<.05 level [F (5, 94) = 29,71, P<0,0001]. A post hoc test using Bonferroni's 
multiple comparisons procedure indicated that the STS-treated single (M = 0,004; SD = 
0,01789; 20 samples) and dual (M = 0,0765; SD = 0,1533; 20 samples) transfected groups 
 
 
Figure 20. Biosensor co-transfected with unlinked CBD28k in 
treated/untreated HN10e cells. 
This box plot diagram shows the effect of CBD28k co-transfection on 
Caspase-3 activity (n = 1; #3 ,#6 each with 10 samples; #1, #2, #4, #5 each 
with 20 samples) with optional STS-treatment (10 µM for 11h). (* = p < 0.05, 
ns = not significant, one-way ANOVA w/ Bonferroni post-hoc test). 
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featuring CD as a morphological marker of advanced apoptosis differed significantly at 
the adjusted p = 0,0141. Due to the distribution, a Mann-Whitney U test was additionally 
conducted, which also showed a significant difference between both groups (U = 149, 
z = -2.083, p = 0.037 [asymp. sig. 2-tailed]). 
However, comparisons between the untreated single (M = 0,1125; SD = 0,03041; 20 
samples) and dual (M = 0,139; SD = 0,06593; 20 samples) transfected groups, and, 
moreover, the STS-treated single (M = 0,299; SD = 0,04358; 10 samples) and dual  
(M = 0,293; SD = 0,04668; 10 samples) transfected groups without CD showed no 
significant differences. Cells were randomly selected without control of co-transfection. 
While 95 % of the exclusively biosensor-transfected samples with CD showed no FRET 
at all, 25 % of the samples from the pool of the dual-transfected cells with CD showed 
high FRET-efficiencies. In addition to that, 15 % of these samples displayed FRET-
efficiencies approximately 3 - 4 times greater than the untreated, exclusively biosensor-
transfected samples.  
FP-conjugated Calbindin-D28k 
A one-way analysis of variance (ANOVA) was used to compare the effect of FP-
conjugated CBD28k co-transfection on Caspase-3 activity among treatment (± STS) and 
apoptotic (± CD) conditions (see figure 22). There was a statistically significant 
difference between group means at the p<.05 level [F (3, 27) = 19,47, P<0,0001]. A post 
hoc test using Bonferroni's multiple comparisons procedure indicated that the untreated 
single (M = 0,164; SD = 0,1085; 10 samples) and dual (M = 0,44; SD = 0,1056; 5 samples) 
transfected groups differed significantly at the adjusted p = 0,0001. 
However, both comparisons between the untreated dual (M = 0,44; SD = 0,1056;  
5 measurements) transfected group either with the STS-treated dual transfected group 
with CD (M = 0,495; SD = 0,1167; 8 samples) or without CD (M = 0,4338; SD = 0,06927; 
8 samples) showed no significant difference. Moreover, there was no significant 
difference between the STS-treated dual transfected group without CD (M = 0,4338; 
SD = 0,06927; 8 samples) and the STS-treated dual transfected group with CD  
(M = 0,495; SD = 0,1167; 8 samples).  
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Samples were randomly selected with control of co-transfection. Samples with low 
absolute intensities (< 104 on a 16-bit scale) in the mTurquoise2-Channel were excluded 
to represent moderate to high expression levels. 
Figure 21 demonstrates Acceptor-Photobleaching performed on samples with high 
cFRET-efficiency even despite the occurrence of CD. 
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Figure 21. mAmetrine-DEVD-tdTomato and mturq2-CBD28k co-transfected samples 
treated with Staurosporine. 
After high-dose STS (15 µM for 4h) treatment, chromatin condensation, a characteristic 
morphological feature of apoptosis, is apparent. (1) Before the bleaching experiment, 2 scans 
were acquired for the purpose of verifying co-transfection, correcting tdTomato’s signal 
increase upon photobleaching and mTurquoise2 SBT. (A) is acquired by mTurquoise2 excitation 
and mTurquoise2 detection, while (B) is acquired by tdTomato excitation and tdTomato 
detection. (2 - 3) mAmetrine (A) and tdTomato Channel (B) are shown before (2) and after (3) 
the bleaching event. The cell on the left (grey arrow) demonstrated a cFRET-efficiency of 0,51, 
while the cell on the right (yellow arrow) shows a cFRET-efficiency of 0,65. 
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Figure 22. Biosensor co-transfected with FP-conjugated CBD28k in treated/untreated HN10e cells. 
(A) The effect of FP-conjugated CBD28k co-transfection on Caspase-3 activity is demonstrated in a box plot 
(n = 1; #1 with 10 samples; #2 with 5 samples; #3, #4 each with 8 samples). Optional STS-treatment (15 µM 
for 4 h). Cells with low absolute intensities <104 in the mTurquoise2-channel were excluded. (*** = p < 0.001, 
ns = not significant, one-way ANOVA w/ Bonferroni post-hoc test). (B) This diagram shows that there 
appears to be a correlation between the measured cFRET-efficiency and the absolute FP intensity. The red 
line shows untreated cells exclusively transfected with the biosensor. The green line represents untreated 
cells transfected with both biosensor and FP-conjugated CBD28k. STS-treated dual-transfected cells without 
CD are demonstrated by the blue line, whereas cells with CD are shown by the yellow line. The dashed line 
indicates the absolute intensity threshold (< 104 on a 16-bit scale) that was applied for the statistical analysis 
in order to represent moderate to high expression levels. 
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3.3. Investigation of intermolecular interaction between Calbindin-
D28k and Pro-Caspase-3 by Acceptor-Photobleaching and 
Sensitized Emission 
Extensive negative and positive control experiments were performed to detect and 
eliminate artefacts from measurements. Each sample was sequentially analyzed, first 
using Sensitized Emission then Photobleaching (see chapter 2.3.). Data is shown as 
mean with standard deviation. An intramolecular FRET construct, mAmetrine-DEVD-
tdTomato, was used as positive control. Uncorrected average FRET-efficiencies were 
close to the previously reported range of 0,42 – 0,45 (Ai et al. 2008). Corrected FRET 
(cFRET) efficiencies (M = 0,275; SD = 0,06364; n = 2; each 10 samples) were slightly 
lower than uncorrected FRET-efficiencies due to the correction of signal increase upon 
photobleaching. Normalized FRET 
(nFRET) efficiencies from 
Sensitized Emission were 
additionally measured as a 
qualitative control (M = 0,305;  
SD = 0,1909; n = 2; each 10 
samples). 
A total of 4 independent negative 
control experiments was 
performed (see figure 23): 
mAmetrine + tdTomato-CASP3  
(15 samples), mAmetrine-CBD28k 
+ tdTomato (6 samples) and the 
unconjugated FPs (n = 2; each 20 
samples) showed similar nFRET-
efficiencies close to zero. 
Remarkably, cFRET-efficiencies in 
all samples equaled zero.  
For the purpose of confirming that high tdTomato concentrations would not lead to 
false positive results due to signal increase upon photobleaching, a small number of 
 
 
Figure 23. Negative and positive controls. 
This diagram shows that there is a significant difference between 
negative controls experiments (n = 4; unlinked mAmetrine and 
tdTomato co-transfection, unlinked mAmetrine and tdTomato-
CASP3 co-transfection (2 exp.), mAmetrine-CBD28k and unlinked 
tdTomato co-transfection) and the positive control experiment  
(n = 2; mAmetrine-DEVD-tdTomato). Data shows mean and SD. 
(* = p < 0.05, *** = p < 0.001, independent student’s t test). 
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cells (5 samples) with high absolute intensity in the tdTomato-Channel was additionally 
measured, which showed similar results. Independent negative control experiments 
were grouped together as control group for statistical analysis.  
Independent student's t tests were conducted to compare positive and negative control 
groups. For Sensitized Emission, there was a statistically significant difference between 
positive (M = 0,305; SD = 0,135; n = 2) and negative (M = 0,0027; SD = 0,001251; n = 4) 
control group; t (4) = 3.656, p = 0,0217, two-tailed. For Photobleaching, there was also 
a significant difference between positive (M = 0,275; SD = 0,045; n = 2) and negative 
(M = 0; SD = 0; n=4) control group; t (4) = 9,979, p = 0,0006, two-tailed.  
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Intermolecular FRET experiments (2 - 4 independent experiments, each with 10 
samples) were performed using mAmetrine-CBD28k as the donor and either tdTomato-
CASP3 or tdTomato-pIMPase as the acceptor in HN10e cells with optional INM 
treatment (2 µM, 24 hours).  
 
 
Figure 24. Intermolecular interaction experiments of mAmetrine-
CBD28k with either tdTomato-pIMPase or tdTomato-CASP3 in co-
transfected HN10e cells. 
Comparison between control and the respective FRET experiments (n = 2 
– 4, each with 10 samples) for both Sensitized Emission (A), 
Photobleaching (B) and optional cytotoxic treatment with Ionomycin 
(INM, 2 µM for 24 hours). Co-transfections of mAmetrine-CBD28k and 
tdTomato-pIMPase without INM-treatment present average FRET 
efficiencies that differ significantly from the control group. Data shows 
mean and S.E.M. (* = p < 0.05, (A) one-way ANOVA w/ Dunnett post-hoc 
test, (B) Kruskal-Wallis test). 
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A one-way analysis of variance (ANOVA) was used to compare nFRET efficiency (from 
Sensitized Emission) of the respective intermolecular interaction experiments (among 
optional treatment conditions with 2 µM INM for 24 hours) with the (negative) control 
group (see figure 24). There was no statistically significant difference between group 
means at the p<.05 level [F (4, 11) = 3,18, P= 0,0577] according to the ANOVA. A post 
hoc test using Dunnett's multiple comparisons procedure indicated that the co-
transfection of mAmetrine-CBD28k and tdTomato-pIMPase without cytotoxic 
treatment (M = 0,0399; SD = 0,02962; n = 3; each 10 samples) differed significantly 
from the control group (M = 0,0027; SD = 0,002502; n = 4) at the adjusted p = 0,0220. 
However, the same co-transfection with INM-treatment (M = 0,013; SD = 0,008485;  
n = 2) showed no significant difference from the control group. There was also no 
significant difference between the control and co-transfections of mAmetrine-CBD28k 
with tdTomato-CASP3 without (M = 0,01125; SD = 0,01018; n = 4) and with  
(M = 0,006333; SD = 0,01012; n = 3) INM-treatment. 
A one-way analysis of variance (ANOVA) was used to compare cFRET efficiency (from 
Photobleaching) of the respective intermolecular interaction experiments (among 
optional treatment conditions with 2 µM INM for 24 hours) with the (negative) control 
group (see figure 24). As Brown-Forsythe test for violation of homogeneity of variance 
was statistically significant at the p<.05 level [F (4, 11) = 3,418, P=0,0476], further 
analysis was conducted using Kruskal-Wallis test. Kruskal-Wallis test showed a 
statistically significant difference between groups at the p<.05 level [H = 14,57,  
p = 0,0002]. Dunn’s post hoc test indicated that the co-transfection of mAmetrine-
CBD28k and tdTomato-pIMPase without cytotoxic treatment (M = 0,03133;  
SD = 0,03197; n = 3; each 10 samples) differed significantly from the control group (M 
= 0; SD = 0; n = 4) at the adjusted p = 0,0150 (with a mean rank difference of -8,667). 
However, the same co-transfection with INM-treatment (M = 0,0035; SD = 0,003536; 
n = 2) showed no significant difference from the control group. There was also no 
significant difference between the control and co-transfections of mAmetrine-CBD28k 
with tdTomato-CASP3 without (M = 0; SD = 0; n = 4) and with (M = 0; SD = 0; n = 3) 
INM-treatment. 
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In order to investigate compartmental FRET, a pixel-by-pixel analysis was performed in 
ImageJ and PixFRET. For this purpose, selected scans (1 – 2 samples; selected on the 
basis of highest nFRET-efficiency) from each transfection were analyzed (with the 
exception of INM-treated samples). The result of the pixel-by-pixel analysis is 
summarized in figure 25. 
 
Figure 25. Pixel-by-pixel analysis of selected cells. 
Mean nFRET (SE) values computationally determined by pixel-by-pixel analysis are respectively demonstrated at 
the top (calculated nFRET values are shown in parenthesis for comparison). Yellow lines indicate respective ROIs.  
(1) Positive and negative control samples: (A) and (B) demonstrate positive controls samples. (C) and (D) are 
unconjugated FP negative control samples. (E) shows mAmetrine + tdTomato-CASP3 and (F) mAmetrine-CASP3 + 
tdTomato co-transfected negative control samples. (2) mAmetrine-CBD28k + pIMPase-tdTomato (set#1: A, B; set#2: 
C, D; set#3: E, F). (3) mAmetrine-CBD82K + CASP3-tdTomato (set#1: A, B; set#2: C, D; set#3: E, F; set#4: G, H). 
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4. Discussion 
To date, evidence on the various intermolecular interactions of CBD28k is still essentially 
based on in-vitro studies (Schmidt 2012). However, occasionally in-vitro studies were 
shown to yield misleading results that do not correspond with conditions in living cells. 
Thus, for the first time to our knowledge, this study investigates the proposed 
intermolecular interaction between CBD28k and Pro-/Caspase-3 and, moreover, the 
inhibition of Caspase-3 activity in a more complex, natural milieu of a cell using in-situ 
FRET microscopy. There is conclusive evidence for a calcium-independent interaction 
between CBD28k and the IMPase target peptide sequence. However, the results do not 
indicate an interaction with Pro-Caspase-3. The pilot experiments indicate inhibition of 
Caspase-3 activity in a concentration-dependent manner. 
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In-situ assay of Caspase-3 activity upon expression of Calbindin-D28k 
The first pilot experiment with unconjugated CBD28k showed that there is a statistically 
significant difference between STS-treated (10 µM for 11 h) single- (exclusively 
biosensor-transfected) and dual-transfected (biosensor and CBD28k) groups featuring 
CD as a morphological marker of advanced apoptosis (see figure 20, chapter 3.2.3.). 
While single-transfected samples showed essentially no FRET after treatment with STS, 
approximately a quarter of the STS-treated dual-transfected samples showed increased 
cFRET-efficiencies and, furthermore, a share displayed substantially greater cFRET-
efficiencies than what was observed in untreated single-transfected samples. This 
indicates that plasmid-induced expression of CBD28k can lead to inhibition of Caspase-
3 activity, which can protect cells from apoptosis. Without control of co-transfection in 
this experiment, one can assume that the level of statistical significance might be 
adversely affected. As anticipated, STS-treated single-transfected and dual-transfected 
samples without CD showed nearly identical cFRET efficiencies. Similar mean cFRET-
efficiency in STS-treated samples without CD and the substantial difference in cFRET-
efficiency to samples featuring CD suggest that the occurrence of chromatin 
compaction serves as a suitable marker for advanced apoptosis. However, a difference 
in cFRET-efficiency between STS-treated samples without CD and untreated single-
transfected samples is present, which might be a response of the HN10e neural cell line 
to cytotoxic treatment, e.g. through increased neurotrophic factor synthesis. 
This pilot experiment was then adapted and modified with FP-labeled CBD28k, which 
enabled screening and validation of co-transfection and, moreover, investigation of 
concentration dependence. Interestingly, no significant difference in cFRET-efficiency 
was found when both untreated and high-dose STS-treated (15 µM for 4 h) dual-
transfected (biosensor and mturq2-CBD28k) samples were compared regardless of the 
occurrence of CD (see figure 22, chapter 3.2.3.). Furthermore, in opposition to the first 
pilot experiment, there was no significant difference in cFRET-efficiency between CD 
positive and negative high-dose STS-treated dual-transfected groups. This suggests 
further that CBD28k overexpression can inhibit Caspase-3 activity in context of high-
dose STS treatment, even despite the occurrence of CD as a distinct morphological 
marker of PCD. The pathway mediating PCD despite blockage of the common caspase-
dependent pathway is known as Caspase-independent cell death (CICD), which shares 
properties with apoptosis, such as peripheral nuclear condensation, partial CD and 
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outer-membrane permeabilization (Tait & Green 2008). Although, in theory, residual 
low-level Caspase-3 activity might also induce morphological characteristics of 
apoptosis, while leaving the biosensor essentially unaffected. 
Comparing untreated single-transfected (exclusively biosensor-transfected) samples 
from the pilot experiments (see figure 20 and 22, chapter 3.2.3.) and the positive control 
(see chapter 3.3.), a small divergence in cFRET-efficiency becomes apparent. As non-
specific cleavage and hydrolysis of the DEVD motif should be negligible, the observed 
difference amongst experiments could be related to the FRET biosensor itself or caused 
by deficiency of growth and survival factors in the cell culture medium leading to 
starvation-induced apoptosis (Braun & Bertin 2011). However, result should remain valid 
for each experiment, as all samples were subject to the same conditions (except for 
optional cytotoxic treatment). But on this account, one might assume that in context of 
CBD28k overexpression starvation-induced Caspase-3 activity was inhibited, leading to 
significantly increased cFRET-efficiency when untreated dual-transfected samples were 
compared with untreated single-transfected samples, which would be consistent with 
observations from the previous experiment with unlabeled CBD28k. 
In order to investigate a link between CBD28k concentration and inhibition of Caspase-
3 activity, the absolute FP intensity, which is dependent on the protein concentration, 
was plotted against the measured cFRET-efficiency. The findings represented in figure 
22 suggest that the inhibition occurs in a concentration-dependent manner with 
approximately linear dependency between CBD28k expression and inhibition of 
Caspase-3 activity. As anticipated, a small share of samples showed no cFRET despite 
high expression of CBD28k, which suggests that there are limits to the inhibitiory effect 
and, furthermore, that the observed effect is not of artificial nature.  A similar 
observation of concentration dependence was previously reported from an in-vitro 
study (Liu et al. 2003).  
These pilot experiments indicate that CBD28k can inhibit Caspase-3 in intact cellular 
systems in a concentration-dependent manner. While these findings would be in 
accordance with various reports suggesting a cytoprotective attribute and protection 
from cell death both in a calcium-dependent and -independent manner (Christakos et 
al. 2003), the results of these pilot experiments need to be interpreted with care, as 
appropriate reproducibility has not been shown yet. Furthermore, there are few report 
62 
stating that no cytoprotective effect was observed in CBD28k null-mutant/-deficient 
mice (Airaksinen et al. 1997b, Klapstein et al. 1998). Given that the inhibition of Caspase-
3 activity occurs in a concentration-dependent manner, these controversial results 
might be linked to age-dependent CBD28k expression (Enderlin et al. 1987, Geng et al. 
2015, Kishimoto et al. 1998, Varghese et al. 1988). Therefore, elevated levels of CBD28k 
in early, critical developmental stages might suffice to protect from cell death, whereas 
in adults, lower concentrations might not be able to prevent apoptosis. Consistently, it 
was shown that expression of CBD28k is frequently downregulated below detection by 
immunohistochemistry once adulthood is reached (Zhang et al. 1990). Alternatively, 
compensatory upregulation of Calbindin-like or closely related proteins as a 
consequence of absolute deficiency of CBD28k (null mutants), could potentially mask 
protective effects. 
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Investigation of intermolecular interaction between Calbindin-D28k and Caspase-3 by 
Acceptor-Photobleaching and Sensitized Emission 
Samples co-transfected with the tdTomato-labeled IMPase target peptide and 
mAmetrine-labeled CBD28k demonstrated statistically significant FRET in both 
Sensitized Emission and Acceptor-Photobleaching (see figure 24, chapter 3.3.). This 
result indicates nanometer-scale co-localization, which is highly suggestive for 
intermolecular protein-protein interaction (Bastiaens & Pepperkok 2000, Grecco & 
Verveer 2011, Sekar & Periasamy 2003). Consistent with several reports, this finding 
provides further evidence for an interaction between CBD28k and the IMPase 
(ISSIKEKYPSHS) target peptide sequence (Almog et al. 2011). Optional treatment with 
INM (2 µM for 24 h), a commonly used ionophore for induction of apoptosis and rise of 
intracellular calcium levels, did not increase FRET-efficiency. While this result is 
consistent with reports stating that the interaction occurs in a calcium-independent 
manner, it is in conflict with a finding suggesting a further boosted interaction at 
increased calcium levels during synaptic activation (Schmidt 2012). 
Samples co-expressing tdTomato-conjugated Pro-Caspase-3 and mAmetrine-
conjugated CBD28k showed no significant difference to the control (see figure 24, 
chapter 3.3.), suggesting that there is no higher degree of co-localization, and, therefore 
these results are not indicative for intermolecular interaction. Remarkably, no FRET was 
observed in any sample using Acceptor-Photobleaching, even when Sensitized 
Emission displayed low, but insignificant FRET-efficiency. While Sensitized Emission is 
commonly viewed as less robust and, hence, is applied in qualitative research, 
Acceptor-Photobleaching is more precise in nature and does not necessarily require 
complex corrective algorithms and corrections factors. The findings of the pIMPase 
experiments suggested that low FRET-efficiencies were not masked by overestimation 
of the corrected signal increase upon photobleaching and, furthermore, that Acceptor-
Photobleaching is the more sensitive method. Therefore, it is concluded that specific 
FRET did not occur in these samples.  
While protein expression of the tdTomato-CASP3 construct was confirmed by both 
Western Blot and immunofluorescence, there is the remote probability that despite its 
linker sequence, the fusion construct might prohibit normal protein folding, which could 
prevent interaction (Miyawaki 2011). Although both tdTomato constructs are of similar 
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dimensions, abnormal size of the fusion construct could potentially affect normal 
protein functioning. However, induction of apoptosis with cleavage of Pro-Caspase-3 
would yield a smaller, cleaved acceptor construct with solely the pro-domain attached 
to tdTomato (see figure 17, chapter 3.1.2.). But optional treatment with INM (2 µM f0r 
24 h) did not result in any noteworthy change. In the case that the proportion of 
interacting molecules from the total of fluorescent molecules were to be exceptionally 
low, specific FRET could potentially be concealed by the overall fluorescent background. 
While interfering endogenous interaction can result in lower apparent FRET-efficiency, 
it is improbable that it eliminates detection of FRET entirely. As outlined, there is a minor 
sequence variation (see figure 17, chapter 3.1.2.) between the Pro-Caspase-3 pro-
domain of Homo sapiens and Mus Musculus. Presuming, that this might cause a 
substantial difference in binding affinity, it is unlikely that this important mechanism, 
affecting an essential effector of apoptosis, is not shared among close genetic relatives, 
when other pro-domain interaction motifs, such as the death effector domain (DED) 
and caspase activation and recruitment domain (CARD), are known to be highly 
conserved in mammals. Although the majority of studies on this subject reported an 
interaction between CBD28k and the active Caspase-3, there were only few studies 
providing evidence that CBD28k might interact with a peptide sequence of the Pro-
Caspase-3 pro-domain (Kojetin et al. 2006, Kordys et al. 2007). Contrary to these in-
vitro experiments, the current study indicates that both proteins might not co-localize, 
suggesting that the inhibition of Caspase-3 activity is attributable to the intermolecular 
interaction with active Caspase-3. 
There were no indications for compartmental FRET (see figure 25, chapter 3.3.). 
Calculated nFRET-efficiencies were consistent with computationally acquired data from 
pixel-by-pixel analysis. Small, artificial hotspots were occasionally associated with the 
cell membrane. Larger darkened hotspots correspond to the localization of the nucleus. 
Pilot experiments have shown that unconjugated tdTomato and its constructs were 
mainly localized in the cytosolic milieu and were excluded from the nucleus, likely due 
to the molecular weight of ≥ 54 kDa, which hinders passive diffusion through the pore 
(Marfori et al. 2011). As a consequence, FRET-efficiencies were slightly lower within the 
nucleus, but in synopsis remained negligible. 
In conclusion, this experiment confirms the interaction between CBD28k and the IMPase 
peptide sequence. There are various reports providing conclusive in-vitro evidence on 
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the interaction with IMPase, RanBPM and active Caspase-3 (Bellido et al. 2000, 
Berggård et al. 2002b, Christakos & Liu 2004, Liu et al. 2003, Lutz et al. 2003, Schmidt 
et al. 2005, Shamir et al. 2005). Additionally, target peptide sequences derived from 
IMPase (ISSIKEKYPSHS) and RanBPM (LASIKNR) were shown to interact with CBD28k 
(Lutz et al. 2003). Based on homology searches, it was later discovered that the Pro-
Caspase-3 pro-domain features a peptide sequence (SKSIKNLEP) with significant 
homology to the other peptides sequences. Further research suggested that CBD28k 
and Pro-Caspase-3 would interact and, additionally, similar binding traits between 
IMPase and Pro-Caspase-3 peptide sequences were observed (Kojetin et al. 2006). 
Another study reported that all 3 target peptide sequences would bind to the same 
binding site, which involves the canonical EF2-hand (Kordys et al. 2007). The report of 
similar binding traits between IMPase and Pro-Caspase-3 peptide sequences suggests 
that the interaction with Pro-Caspase-3 would be comparable to that of the IMPase 
target peptide (Kojetin et al. 2006). Therefore, it is unexpected, that no clear indications 
could be found for an intermolecular interaction between CBD28k and Pro-Caspase-3. 
While the body of evidence for an interaction with active Caspase-3 is conclusive, the 
interaction with its zymogen remains open to question. According to Chang and Yang 
(2000), it is unlikely that the pro-domains of executioner caspases facilitate 
interm0lecular interaction. However, there is evidence that the pro-domain suppresses 
spontaneous activation of Pro-Caspase-3 to protect against low-level, latent initiator 
caspase activity (Meergans et al. 2000). Other studies suggested that removal of the 
pro-domain from Drosophila melanogaster effector caspases, drICE and DCP-1, 
enhances caspase activity (Berg et al. 2012, Song et al. 1997). 
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Limitations 
The assay of protein interaction using FRET applications should always have a scientific 
rationale, such as in-vitro studies providing indications for a possible interaction, as co-
localization does not necessarily involve intermolecular interaction. Thus, FRET, which 
only occurs in nanometer scale proximity and, hence, is highly suggestive for such a 
protein-protein interaction (Sekar & Periasamy 2003), needs to be carefully interpreted 
in synopsis with other reports. 
During the pilot experiments, tdTomato or tdTomato-CASP3-transfected samples 
showed a signal increase in the mAmetrine-Channel upon photobleaching. Due to 
sample fixation and the bleaching of the cell’s soma, focal drift and acceptor influx were 
considered implausible. However, there are various reports stating that DsRed, common 
origin of the red FP fruit series (Shaner et al. 2004), might display a green state, which 
was suggested to be either attributable to immature chromophores within the tetramer 
or direct photoconversion (Kremers et al. 2009, Marchant et al. 2001). DsRed is known 
to exhibit a long maturation process, which can lead to FRET between immature green- 
and mature red-emitting species (Robinson & Marchant 2005). In view of tdTomato’s 
fast maturation rate, immature chromophores within tdTomato might have lower 
impact on FRET-efficiency compared with DsRed. However, the occurrence of partial 
photoconversion would be consistent with other studies suggesting that 
photoconversion among red and orange fluorescent proteins might be common 
(Kremers et al. 2009). Partial photoconversion was also reported to occur in cyan 
fluorescent protein (CFP)-yellow fluorescent protein (YFP)-FRET-experiments, where 
YFP is photoconvertible upon photobleaching, leading to an increase in cyan 
fluorescence (Kirber et al. 2007, Valentin et al. 2005). Photoconversion was not a 
substantial issue in most cases and, hence, was mathematically corrected (Seitz et al. 
2012). Nevertheless, there is no scientific consensus regarding the photoconversion of 
YFP (Verrier & Söling 2006). In most cases, the photoconvertible species is reported to 
exhibit mono-exponential increase and photoconversion rates increase supra-linearly 
with rising laser power (Kremers et al. 2009). The observed gradual recovery of 
TdTomato signal is likely due to spontaneous recovery of immature green-emitting 
chromophores to red-emitting mature chromophores. In case of YFP, there was a 
similar report of photobleaching and spontaneous recovery after strong irradiation 
(Dickson et al. 1997, Miyawaki 2011). In summary, photoconversion can prove 
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problematic in intermolecular FRET experiments with particularly low FRET-efficiencies 
and high concentrations of the photoconvertible protein. Thus, photoconversion should 
be corrected with an appropriate corrective approach. For this purpose, a 
photoconversion correction factor was established to eliminate these artefacts. 
The current data suggests that non-specific FRET due to high protein concentrations 
was no substantial limitation of this study. Common issues of experimental works 
implementing plasmid transfections and FRET applications were addressed in the 
methods section and adequate preventive arrangements were taken. 
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Implications and further research 
It was shown that expression of CBD28k plays a role in a subset of medulloblastomas, 
a brain tumor with high malignancy frequently seen in younger patients. 
Immunohistochemical positivity for CBD28k was significantly associated with poor 
prognosis and, therefore, was proposed to represent a subclass of particularly 
aggressive tumors (Katsetos et al. 1995, Pelc et al. 2002). Other studies reported that 
lung cancer cells express CBD28k at significantly higher levels than non-cancerous lung 
tissue (Castro et al. 2000, Watanabe et al. 1994). Hence, blocking Caspase-3 inhibition 
to sensitize tumor cells for chemo- or radiotherapy may present a new therapeutic 
option for some patients. Druggablity and cyclic peptide binding analysis of CBD28k 
confirmed that peptide therapeutics might be used to block the interaction with 
Caspase-3 by changing conformational and dynamic properties (Bobay et al. 2014).  
Dysfunctional execution of PCD was suggested to be associated with many 
neurodegenerative disorders, such as Parkinson’s disease (PD) or Chorea Huntington 
(HD) (Elmore 2007). Altered expression of CBD28k was observed in diseases such as 
Alzheimer’s disease (AD), Down’s syndrome, ischemia and epilepsy (Heizmann & Braun 
1992). Comparison of human brain tissue showed that there is a significant decrease of 
CALB1 gene expression in aging and neurodegenerative diseases, particularly in brain 
samples of substantia nigra (PD), the corpus striatum (HD), nucleus basalis of Meynert 
and hippocampus (AD) (Iacopino & Christakos 1990). Recently it was discovered that a 
dysfunction of the (PARK14-dependent) calcium homeostasis and signaling, caused by 
a defect of the PLA2g6 protein, is strongly related to cell death in idiopathic Parkinson's 
disease (Zhou et al. 2016). Various studies reported that dopaminergic neurons in a 
MPTP-induced PD model showed increased resistance to cell death when CBD28k was 
expressed (Choi et al. 2008, Crocker et al. 2003, German et al. 1992, Sheehan et al. 
1997). Given these points, further investigation of the mechanisms underlying the anti-
apoptotic function of CBD28k might help to develop new pharmacological treatments 
and distinct therapeutic strategies. Most available inhibitors of initiator caspases were 
shown to be either ineffective or resistance was rapidly developed (Bobay et al. 2014). 
Despite the advancements in the development of cytoprotective agents, there are no 
clinically-established caspase-3-inhibitors in therapeutic use. To date, most pre-clinical 
studies were performed with active-site inhibitors (Bobay et al. 2012). However, 
experiments with isolated peptide sequences obtained from CBD28k were unable to 
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inhibit Caspase-3 (Liu et al. 2003). A deeper understanding of how CBD28k inhibits 
Caspase-3 might prove beneficial to develop alternate solutions such as peptide 
therapeutics or synthetic structure mimetics. Development of new cytoprotective 
agents inhibiting active Caspase-3 might help to prevent apoptosis in ischemia, 
neurodegenerative diseases and a plethora of other diseases.  While FRET experiments 
are commonly used to provide evidence for intermolecular interaction, negative results 
do not necessarily imply that there is no interaction between both target proteins. 
Hence, further research is necessary to rule out an interaction with Pro-Caspase-3. 
In addition to the inhibition of Caspase-3 activity and buffering of calcium, there are 
indications for alternate pathways (Choi et al. 2008). It was shown that CBD28k 
expressing endometrial cancer cells, treated with hydrogen peroxide, showed 
decreased expression of pro-apoptotic Bax, p53 and Bcl-2 (Jung et al. 2011). Another 
study proposed that CBD28k might exhibit cytoprotection by modulation of ERK1/2, 
which can promote cell survival. (Liu et al. 2003). A similar finding showed that injection 
of GDNF leads to increased expression of CBD28k, which was accompanied by 
activation of ERK1/2 (Wang et al. 2008). Therefore, we propose that the interaction with 
RanBPM (Lutz et al. 2003), particularly a cytoprotective modulation of the Ras-Raf-MEK-
ERK-pathway (Atabakhsh & Schild 2012, Meloche & Pouyssegur 2007) and, moreover, 
an effect on the binding capacity of p73alpha (Kramer et al. 2004), a protein with 
structural and functional similarity with the p53 tumor suppressor (Courtois et al. 2004), 
might be interesting subjects for future research. 
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5. Summary 
In conclusion, CBD28k is an important cytoprotective effector, particularly during critical 
developmental stages of neuronal maturation. While its neuronal expression essentially 
occurs in a coordinated, maturation-dependent manner, it was also demonstrated that 
cytotoxic stimuli such as mechanical trauma or tumor necrosis factors (TNFs) can also 
induce expression of CBD28k in the central nervous system (Mattson et al. 1995). The 
present body of evidence suggests that this cytoprotective effect is mediated through 
direct inhibition of active Caspase-3 in a concentration dependent manner. However, 
there is growing evidence that other protective pathways might also exist.  
Key findings: 
 Conclusive evidence for a calcium-independent interaction between CBD28k 
and IMPase target peptide sequence, while no clear indications were found for 
an interaction with Pro-Caspase-3. Occurrence of FRET was not limited to 
subcellular compartments. 
 Pilot experiments indicate that CBD28k can inhibit Caspase-3 activity in a 
concentration-dependent manner. 
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Appendix 
Suppl.: pCMV5 plasmid 
Suppl.: mAmetrine forward and reverse primer 
Suppl.: CBD28k forward and reverse primer 
Suppl.: tdTomato forward and reverse primer 
Suppl.: CASP3 forward and reverse primer 
Suppl.: IMPase secondary structure 
Suppl.: pIMPase design and construction 
Suppl.: mAmetrine (w/ linker and w/o TAA stop codon) + EcoR1 + CBD28k  
(w/ stop codon) inserted in pCMV5 MCS 
Suppl.: TdTomato (w/o TAA stop codon) + Kpn1 + GTT-Linker + CASP3  
(w/ stop codon) inserted in pCMV5 MCS 
Suppl.: tdTomato (w/o TAA stop codon) + Kpn1 + Linker + partial IMPase 
sequence (w/ stop codon) inserted in pCMV5 MCS 
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Forward primer: 
1. 5'‐N6‐gaattc‐ 
ATG‐GTG‐AGC‐AAG‐GGC‐GAG‐3' 
-EcoR1: 5'-g/aattc-3'- 
Gene specific part of mAmetrine 
from the mAmetrine-DEVD-
dtTomato sequence 
    
2. 5'‐N6‐gaattc‐ 
ACC‐ATG‐GTG‐AGC‐AAG‐GGC‐3' 
In accordance with the Kozak rule, 
the upstream ACC codon from the 
original mAmetrine-DEVD-tdTomato 
sequence was included and the 
downstream GAG from the draft was 
removed in order to preserve the 
primer's length. 
    
3. 5'‐N6‐gaattc‐ 
GCC‐ACC‐ATG‐GTG‐AGC‐AAG‐3' 
Then the 3'-GC clamp (downstream 
GGC) was removed in order to 
prevent unwanted stronger 3' 
binding to the DNA. 
In order to preserve the primer's 
length, the upstream GCC codon 
from the original mAmetrine-DEVD-
tdTomato sequence was included. 
    
4. 5'‐GAC‐TAT‐gaattc‐ 
GCC‐ACC‐ATG‐GTG‐AGC‐AAG‐3' 
In regard of an optimal annealing 
temperature and prevention of 
unwanted loop formation this N6 
sequence was chosen. 
 
Gene specific part of the primer: 
61 % GC content 
39 % AT content 
 
Complete primer: 
50 % GC content 
50 % AT content 
Reverse primer: 
1. 5'‐N6‐aagctt‐ 
ACC‐GGC‐AGT‐GGC‐AGC‐GGA‐3' 
-Hind3: 5'-a/agctt-3'- 
mAmetrine-DEVD-dtTomato 
sequence including the plasmid 
linker: 
ggt-acc-ggc-agt-ggc-agc-gga 
(protein translation: GTGSGSG) 
Part of the linker was used as the 
gene specific part (preserving the 
functional linker): 
5'-acc-ggc-agt-ggc-agc-gga-3' 
    
2. 5'‐N6‐aagctt‐ 
ACC‐GGC‐AGT‐GGC‐AGT‐GGA‐3' 
The GC content of the gene specific 
part of the primer was reduced from 
72 % to 67 % by exchanging the 
Suppl.: mAmetrine forward and reverse primer 
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AGC codon for an AGT codon 
(alternate codon for Serine). 
    
3. 5'‐N6‐aagctt‐ 
TCC‐ACT‐GCC‐ACT‐GCC‐GGT‐3' 
The reverse complement of the gene 
specific part was created. 
    
4. 5'‐TAG‐ATC‐aagctt‐ 
TCC‐ACT‐GCC‐ACT‐GCC‐GGT‐3' 
In regard of an optimal annealing 
temperature and prevention of 
unwanted loop formation this N6 
sequence was chosen. 
 
Gene specific part of the primer: 
67 % GC content 
33 % AT content 
 
Complete primer: 
53 % GC content 
47 % AT content 
 
NEB TM calculator [Phusion High-Fidelity DNA Polymerase (HF Buffer], 500 nM) 
Gene specific part: 
Anneal Temp: 66 °C 
Forward primer: 66 °C 
(GCCACCATGGTGAGCAAG)  
Reverse primer: 71 °C 
(TCCACTGCCACTGCCGGT)  
[Tm difference is at the recommended limit of 5 °C.] 
Complete primer: 
Anneal Temp: 72 °C 
Forward primer: 76 °C 
(GACTATGAATTCGCCACCATGGTGAGCAAG) 
Reverse primer: 79 °C 
(TAGATCAAGCTTTCCACTGCCACTGCCGGT) 
 
 
PCR simulation created with Serial Cloner 2.61 
 
Suppl.: CBD28k forward and reverse primer 
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Forward primer: 
1. 5'‐N6‐aagctt‐ 
ATG‐GCA‐GAA‐TCC‐CAC‐CTG‐3' 
-Hind3: 5'-a/agctt-3'- 
Gene specific part from the Mus 
Musculus Calbindin 1 sequence 
    
2. 5'‐N6‐aagctt‐ 
ACG‐ATG‐GCA‐GAA‐TCC‐CAC‐3' 
In accordance with the Kozak rule, 
the upstream ACG codon from the 
original Mus Musculus Calbindin 1 
sequence was included and the 
downstream CTG from the draft was 
removed in order to preserve the 
primer's length. 
    
3. 5'‐N6‐aagctt‐ 
ACC‐ACG‐ATG‐GCA‐GAA‐TCC‐3' 
56 % GC content of the gene specific 
part of the primer is in the 
recommended range of 40 – 60 %. 
The 3'-GC clamp (downstream CAC) 
was removed in order to prevent 
unwanted stronger 3' binding to the 
DNA.  
In order to preserve the primer's 
length, the upstream ACC codon 
from the original Mus Musculus 
Calbindin 1 sequence was included. 
    
4. 5'‐N6‐aagctt‐ 
ACT‐ACG‐ATG‐GCA‐GAA‐TCC‐3' 
Due to a calculated Tm difference of 
10 °C, the ACC codon of the primer's 
gene specific part was exchanged 
for an ACT codon (alternate codon 
for Threonine). 
    
5. 5'‐TAA‐GTA‐aagctt‐ 
ACT‐ACG‐ATG‐GCA‐GAA‐TCC‐3' 
In regard of an optimal annealing 
temperature and prevention of 
unwanted loop formation this N6 
sequence was chosen. 
 
Gene specific part of the primer: 
56 % GC content 
44 % AT content 
 
Complete primer:  
43 % GC content 
57 % AT content 
Reverse primer: 
1. 5'‐N6‐ggatcc‐ 
TCT‐GCT‐GGA‐GAC‐AAC‐TAG‐3' 
-BamH1: 5'-g/gatcc-3'- 
Gene specific part from the Mus 
Musculus Calbindin 1 sequence 
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2. 5'‐N6‐ggatcc‐ 
CTA‐GTT‐GTC‐TCC‐AGC‐AGA‐3' 
The reverse complement of the gene 
specific part was created. 
    
3. 5'‐TAA‐GTA‐ggatcc‐ 
CTA‐GTT‐GTC‐TCC‐AGC‐AGA‐3' 
In regard of an optimal annealing 
temperature and prevention of 
unwanted loop formation this N6 
sequence was chosen. 
 
Gene specific part of the primer: 
50 % GC content 
50 % AT content 
 
Complete primer:  
47 % GC content 
53 % AT content 
 
NEB TM calculator [Phusion High-Fidelity DNA Polymerase (HF Buffer], 500 nM) 
Gene specific part: 
Anneal Temp: 54 °C 
Forward primer: 58 °C 
(ACTACGATGGCAGAATCC)  
Reverse primer: 54 °C 
(CTAGTTGTCTCCAGCAGA) 
 
Complete primer: 
Anneal Temp: 70 °C 
Forward primer: 67 °C 
(TAAGTAAAGCTTACTACGATGGCAGAATCC) 
Reverse primer: 70 °C 
(TAAGTAGGATCCCTAGTTGTCTCCAGCAGA) 
 
PCR simulation created with Serial Cloner 2.61 
 
Suppl.: tdTomato forward and reverse primer 
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Forward primer: 
1. 5'‐N6‐gaattc‐ 
ATG‐GTG‐AGC‐AAG‐GGC‐GAG‐3' 
-EcoRI: 5'-G/AATTC-3'- 
Gene specific part of tdTomato from 
the mAmetrine-DEVD-dtTomato 
sequence 
    
2. 5'‐N6‐gaattc‐ 
GGT‐ATG‐GTG‐AGC‐AAG‐GGC‐3' 
In accordance with the Kozak rule, 
the upstream GGT codon from the 
original mAmetrine-DEVD-tdTomato 
sequence was included and the 
downstream GAG from the draft was 
removed in order to preserve the 
primer's length. 
    
3. 5'‐N6‐gaattc‐ 
GAT‐GGT‐ATG‐GTG‐AGC‐AAG‐3' 
Then the 3'-GC clamp (downstream 
GGC) was removed in order to 
prevent unwanted stronger 3' 
binding to the DNA. 
In order to preserve the primer's 
length, the upstream GAT codon 
from the original mAmetrine-DEVD-
tdTomato sequence was included. 
    
4. 5'‐TAT‐GTA‐gaattc‐ 
GAT‐GGT‐ATG‐GTG‐AGC‐AAG‐3' 
In regard of an optimal annealing 
temperature and prevention of 
unwanted loop formation this N6 
sequence was chosen. 
 
Gene specific part of the primer: 
50 % GC content 
50 % AT content 
 
Complete primer:  
40 % GC content 
60 % AT content 
Reverse primer: 
1. 5'‐N6‐ggtacc‐ 
ATG‐GAC‐GAG‐CTG‐TAC‐AAG‐3' 
-KpnI: 5'-ggtac/c-3'- 
Gene specific part of tdTomato from 
the mAmetrine-DEVD-dtTomato 
sequence without stop codon TAA 
    
2. 5'‐N6‐ggtacc‐ 
CTT‐GTA‐CAG‐CTC‐GTC‐CAT‐3' 
The reverse complement of the gene 
specific part was created. 
    
3. 5'‐CAC‐CTA‐ggtacc‐ 
CTT‐GTA‐CAG‐CTC‐GTC‐CAT‐3' 
In regard of an optimal annealing 
temperature and prevention of 
Suppl.: tdTomato forward and reverse primer 
87 
unwanted loop formation this N6 
sequence was chosen. 
 
Gene specific part of the primer: 
50 % GC content 
50 % AT content 
 
Complete primer:  
53 % GC content 
47 % AT content 
 
NEB TM calculator [Phusion High-Fidelity DNA Polymerase (HF Buffer], 500 nM) 
Gene specific part: 
Anneal Temp: 53 °C 
Forward primer: 56 °C 
(GATGGTATGGTGAGCAAG)  
Reverse primer:53 °C 
(TACCTTGTACAGCTCGTC) 
 
Complete primer: 
Anneal Temp: 72 °C 
Forward primer: 70 °C 
(TATGTAGAATTCGATGGTATGGTGAGCAAG) 
Reverse primer: 73 °C 
(CACCTAGGTACCCTTGTACAGCTCGTCCAT) 
 
PCR simulation created with Serial Cloner 2.61 
 
Suppl.: CASP3 forward and reverse primer 
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Forward primer: 
1. 5'‐N6‐ggtacc‐ 
ATG‐GAG‐AAC‐AAC‐AAA‐ACC‐3' 
-KpnI: 5'-ggtac/c-3'- 
Gene specific part from the Mus 
Musculus Casp3 sequence 
    
2. 5'‐N6‐ggtacc‐ 
ACC‐ATG‐GAG‐AAC‐AAC‐AAA‐3' 
In accordance with the Kozak rule, 
the upstream ACC codon from the 
original RIKEN CASP3 sequence was 
included and the downstream ACC 
from the draft was removed in order 
to preserve the primer's length. 
 
39 % GC content of the gene specific 
part of the primer is almost in the 
recommended range of 40 – 60 %. 
    
3. 5'‐GGT‐CGT‐ggtacc‐ 
ACC‐ATG‐GAG‐AAC‐AAC‐AAA‐3' 
In regard of an optimal annealing 
temperature and prevention of 
unwanted loop formation this N6 
sequence was chosen. 
 
Gene specific part of the primer: 
39 % GC content 
61 % AT content 
 
Complete primer: 
50 % GC content 
50 % AT content 
    
Reverse primer: 
1. 5'‐N6‐atcgat‐ 
CTG‐TAC‐TTT‐TAT‐CAC‐TAG‐3' 
-ClaI: 5'-at/cgat-3'- 
Gene specific part from the Mus 
Musculus CASP3 sequence 
    
2. 5'‐N6‐atcgat‐ 
CTA‐GTG‐ATA‐AAA‐GTA‐CAG‐3' 
The reverse complement of the gene 
specific part was created. 
    
3. 5'‐GCG‐GGC‐atcgat‐ 
CTA‐GTG‐ATA‐AAA‐GTA‐CAG‐3' 
In regard of an optimal annealing 
temperature and prevention of 
unwanted loop formation this N6 
sequence was chosen. 
 
Gene specific part of the primer: 
33 % GC content 
67 % AT content 
 
Complete primer: 
47 % GC content 
53 % AT content 
 
Suppl.: CASP3 forward and reverse primer 
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NEB TM calculator [Phusion High-Fidelity DNA Polymerase (HF Buffer], 500 nM) 
Gene specific part: 
Anneal Temp: 40 °C 
Forward primer: 56 °C 
(ACCATGGAGAACAACAAA)  
Reverse primer: 40 °C 
(CTAGTGATAAAAGTACAG) 
 
Complete primer: 
Anneal Temp: 72 °C 
Forward primer: 77 °C 
(GGTCGTGGTACCACCATGGAGAACAACAAA) 
Reverse primer: 72 °C 
(GCGGGCATCGATCTAGTGATAAAAGTACAG) 
 
PCR simulation created with Serial Cloner 2.61 
 
Suppl.: IMPase secondary structure 
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PSIPRED secondary structure prediction 
 
 
*green: helix building sequence w/ interaction site 
*yellow: 12 amino acid interaction site 
Suppl.: IMPase secondary structure 
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PSSpred 
 
 
Suppl.: pIMPase design and construction 
92 
IMPase interaction site (with helix):  
LVTVTDQKVEKML‐MSSIKEKYPCHS‐FIGEE (residues 42 - 71) 
The following linker was chosen due to its favorable secondary structure: 
GTGSGSGSGSTG (considered alternatives: EAAA, GSGSGSG, EAAAK, EEEKKKK) 
An oligopeptide was designed and constructed with additional KpnI (5'‐GGTAC/C‐3') 
and ClaI (5'‐AT/CGAT‐3') restriction sites and N6 sequence: 
GTGSGSGSGSTGLVTVTDQKVEKMLMSSIKEKYPCHSFIGEE 
 
 Reverse Translation: 
 
GGCACCGGCAGCGGCAGCGGCAGCGGCAGCACCGGCCTGGTGACCGTGACCGACCAGAAGGTGGAGAA
GATGCTGATGAGCAGCATCAAGGAGAAGTACCCCTGCCACAGCTTCATCGGCGAGGAGTGA 
 
 Addition of restriction sites and N6 sequence: 
 
GTA‐GGC‐GGT‐ACC‐GGC‐ACC‐GGC‐AGC‐GGC‐AGC‐GGC‐AGC‐GGC‐AGC‐ACC‐GGC‐CTG‐
GTG‐ACC‐GTG‐ACC‐GAC‐CAG‐AAG‐GTG‐GAG‐AAG‐ATG‐CTG‐ATG‐AGC‐AGC‐ATC‐AAG‐
GAG‐AAG‐TAC‐CCC‐TGC‐CAC‐AGC‐TTC‐ATC‐GGC‐GAG‐GAG‐TGA‐TAA‐ATC‐GAT‐TAG‐
CGC 
 
 
Oligopeptide primer pair (Annealing temperature: 68 °C | 5 cycles): 
5'‐GTA‐TTA‐GGT‐ACC‐GGA‐AGT‐GGA‐AGC‐GGC‐AGC‐GGC‐AGC‐GGC‐AGC‐ACC‐GGC‐
CTG‐GTG‐ACC‐GTG‐ACC‐GAC‐CAG‐AAG‐GTG‐GAG‐AAG‐ATG‐CTG‐3' 
 
5'‐GCG‐CTA‐ATC‐GAT‐TTA‐TCA‐CTC‐CTC‐GCC‐GAT‐GAA‐GCT‐GTG‐GCA‐GGG‐GTA‐
CTT‐CTC‐CTT‐GAT‐GCT‐GCT‐CAT‐CAG‐CAT‐CTT‐CTC‐CAC‐CTT‐CTG‐GTC‐3' 
 
 
Amplification forward primer (Kpn1): 
 
5'‐GTA‐TTA‐ggt‐acc‐GGA‐AGT‐GGA‐3' 
 
Amplification reverse primer (Cla1): 
 
5'‐GCG‐CTA‐atc‐gat‐TTA‐TCA‐CTC‐3' 
 
Annealing temperature: 61 °C | 30 cycles 
Suppl.: mAmetrine (w/ linker and w/o TAA stop codon) + EcoR1 + 
CBDK28k (w/ stop codon) inserted in pCMV5 MCS 
93 
green = mAmetrine 
red = linker region 
blue = CBD28k 
 
5’‐ATAGAGAGCTCGTTTAGTGAACCGTCA 
G/AATTC 
GCCACCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTA
AACGGCCACAAGTTCAGCGTGCGCGGCGAGGGCGAGGGCGATGCCACCAACGGCAAGCTGACCCTGAAGTTCATC
TGCACCTCCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGTCTTACGGCGTGCAGTGCTTCGCC
CGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACC
ATCTCCTTCAAGGACGACGGCAGCTACAGGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGC
ATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACATGAACGTG
TGGGACGCGTATATCACGGCCGACAAGCAGAAGAACGGCATCAAAGCGAACTTCAAGATCGAGCACAACGTCGAG
GACGGCGGCGTGCAGCTCGCCGACGCGTACCAGCAGAACACCCCCATCGGCGACGGCTCCGTGCTGCTGCCTGAC
AACCACTACCTGAGCTTCCAGAGCAAGCTGTTCAAAGACCCCAACGAGCAGCGCGATCACATGGTCCTGCTGGAG
TTCGTTACCGCCGCCGGGATCACTCTCGGC 
GGTACCGGCAGTGGCAGTGGA 
A/AGCTT 
ACCACGATGGCAGAATCCCACCTGCAGTCATCTCTGATCACAGCCTCACAGTTTTTTGAGATCTGGCTTCATTTC
GACGCTGACGGAAGTGGTTACCTGGAAGGAAAGGAGCTGCAGAACTTGATCCAGGAGCTTCTGCAGGCGCGAAAG
AAGGCTGGATTGGAGCTATCACCGGAAATGAAATCCTTTGTGGATCAATATGGACAGAGAGATGATGGAAAAATA
GGAATTGTAGAGTTGGCTCACGTCTTACCCACAGAAGAGAATTTCTTGCTGCTCTTTCGATGCCAGCAACTGAAG
TCCTGCGAGGAATTCATGAAGACTTGGAGAAAGTATGATACTGACCACAGCGGCTTCATCGAAACCGAGGAACTT
AAGAACTTTCTAAAGGACCTACTAGAGAAAGCAAACAAGACTGTGGATGATACAAAACTAGCAGAGTACACAGAC
CTCATGCTGAAACTATTTGATTCAAATAATGACGGAAAGCTGGAACTGACAGAGATGGCCAGGTTACTACCAGTG
CAGGAAAATTTCCTTCTTAAATTCCAGGGAATCAAAATGTGTGGGAAAGAGTTCAATAAGGCTTTTGAGTTATAT
GATCAGGATGGCAACGGATACATAGATGAAAATGAGCTGGATGCTTTGCTGAAAGATCTGTGTGAGAAGAACAAA
CAGGAATTGGATATTAACAATATTACTACATACAAGAAGAACATAATGGCCTTGTCGGATGGAGGGAAGCTGTAC
CGAACAGACCTTGCTCTTATTCTTTCTGCTGGAGACAACTAG 
G/GATCC 
CGGGTGGCATCCCTGTGACCCCTCCCCAGTGCCTCTCCTGGCCCTGGAAGTTGCCACTCCAGTGCCCACCAGCCT
TGTCCTAATAAAATTAAGTTGCATCATTTTGTCTGACTAGGTGTCCTTCTATAATATTATGGGGTGGAGGGGGGT
GGTATGGAGCAAGGGGCAAGTTGGGAAGACAACCTGTAGGGCCTGCGGGGTCTATTGGGAACCAAGCTGGAGTGC
AGTGGCACAATCTTGGCTCACTGCAATCTCCGCCTCCTGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCGAGTT
GTTGGGATTCCAGGCATGCATGACCAGGCTCAGCTAATTTTTGTTTTTTTGGTAGAGACGGGGTTTCACCATATT
GGCCAGGCTGGTCTCCAACTCCTAATCTCAGGTGATCTACCCACCTTGGCCTCCCAAATTGCTGGGATTACAGGC
GTGAACCACTGCTCCCTTCCCTGTCCTTCTGATTTTAAAATAACTATACCAGCAGGAGGACGTCCAGACACAGCA
TAGGCTACCTGGCCATGCCCAACCGGTGGGACATTTGAGTTGCTTGCTTGGCACTGTCCTCTCATGCGTTGGGTC
CACTCAGTAGATGCCTGTTGAATTGGGTACGCGGCCAGCTTGGCTGTGGAATGTGTGTCAGTTAGGGTGTGGAAA
GTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTC
CCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAAC
TCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTA
TGC‐3’ 
   
Suppl.: mAmetrine (w/ linker and w/o TAA stop codon) + EcoR1 + 
CBDK28k (w/ stop codon) inserted in pCMV5 MCS 
94 
TRANSLATION (57 kDa): 
MVSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTSGKLPVPWPTLVTTLSYGVQCFARY
PDHMKQHDFFKSAMPEGYVQERTISFKDDGSYRTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNMNVWD
AYITADKQKNGIKANFKIEHNVEDGGVQLADAYQQNTPIGDGSVLLPDNHYLSFQSKLFKDPNEQRDHMVLLEFV
TAAGITLGGTGSGSGKLTTMAESHLQSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSP
EMKSFVDQYGQRDDGKIGIVELAHVLPTEENFLLLFRCQQLKSCEEFMKTWRKYDTDHSGFIETEELKNFLKDLL
EKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFLLKFQGIKMCGKEFNKAFELYDQDGNGYI
DENELDALLKDLCEKNKQELDINNITTYKKNIMALSDGGKLYRTDLALILSAGDN* 
 
 
Suppl.: TdTomato (w/o TAA stop codon) + Kpn1 + GTT-Linker + 
CASP3 (w/ stop codon) inserted in pCMV5 MCS 
95 
green = tdTomato 
red = linker region 
blue = CASP3 
 
5’‐ATAGAGAGCTCGTTTAGTGAACCGTCA 
G/AATTC 
GATGGTATGGTGAGCAAGGGCGAGGAGGTCATCAAAGAGTTCATGCGCTTCAAGGTGCGCATGGAGGGCTCCATG
AACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAG
GTGACCAAGGGCGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCCCAGTTCATGTACGGCTCCAAGGCGTAC
GTGAAGCACCCCGCCGACATCCCCGATTACAAGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATG
AACTTCGAGGACGGCGGTCTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCACGCTGATCTACAAGGTG
AAGATGCGCGGCACCAACTTCCCCCCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCACC
GAGCGCCTGTACCCCCGCGACGGCGTGCTGAAGGGCGAGATCCACCAGGCCCTGAAGCTGAAGGACGGCGGCCAC
TACCTGGTGGAGTTCAAGACCATCTACATGGCCAAGAAGCCCGTGCAACTGCCCGGCTACTACTACGTGGACACC
AAGCTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAGCGCTCCGAGGGCCGCCACCAC
CTGTTCCTGGGGCATGGCACCGGCAGCACCGGCAGCGGCAGCTCCGGCACCGCCTCCTCCGAGGACAACAACATG
GCCGTCATCAAAGAGTTCATGCGCTTCAAGGTGCGCATGGAGGGCTCCATGAACGGCCACGAGTTCGAGATCGAG
GGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGCGGCCCCCTGCCC
TTCGCCTGGGACATCCTGTCCCCCCAGTTCATGTACGGCTCCAAGGCGTACGTGAAGCACCCCGCCGACATCCCC
GATTACAAGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGTCTGGTG
ACCGTGACCCAGGACTCCTCCCTGCAGGACGGCACGCTGATCTACAAGGTGAAGATGCGCGGCACCAACTTCCCC
CCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCACCGAGCGCCTGTACCCCCGCGACGGC
GTGCTGAAGGGCGAGATCCACCAGGCCCTGAAGCTGAAGGACGGCGGCCACTACCTGGTGGAGTTCAAGACCATC
TACATGGCCAAGAAGCCCGTGCAACTGCCCGGCTACTACTACGTGGACACCAAGCTGGACATCACCTCCCACAAC
GAGGACTACACCATCGTGGAACAGTACGAGCGCTCCGAGGGCCGCCACCACCTGTTCCTGTACGGCATGGACGAG
CTGTACAAG 
GGTAC/C 
ACCATGGAGAACAACAAAACCTCAGTGGATTCAAAATCCATTAATAATTTTGAAGTAAAGACCATACATGGGAGC
AAGTCAGTGGACTCTGGGATCTATCTGGACAGTAGTTACAAAATGGATTATCCTGAAATGGGCATATGCATAATA
ATTAATAATAAGAACTTCCATAAGAGCACTGGAATGTCATCTCGCTCTGGTACGGATGTGGACGCAGCCAACCTC
AGAGAGACATTCATGGGCCTGAAATACCAAGTCAGGAATAAAAATGATCTTACTCGTGAAGACATTTTGGAATTA
ATGGATAGTGTTTCTAAGGAAGATCATAGCAAAAGGAGCAGCTTTGTGTGTGTGATTCTAAGCCATGGTGATGAA
GGGGTCATTTATGGGACAAATGGGCCTGTTGAACTGAAAAAGTTGACTAGCTTCTTCAGAGGCGACTACTGCCGG
AGTCTGACTGGAAAGCCGAAACTCTTCATCATTCAGGCCTGCCGGGGTACGGAGCTGGACTGTGGCATTGAGACA
GACAGTGGGACTGATGAGGAGATGGCTTGCCAGAAGATAGCCGGTGGAGGCTGACTTCCTGTATGCTTACTCTAC
AGCACCTGGTTACTATTCCTGGAGAAATTCAAAGGACGGGTCGTGGTTCATCCAGTCCCTTTGCAGCATGCTGAA
GCTGTACGCGCACAAGCTAGAATTTATGCACATTCTCACTCGCGTTAACAGGAAGGTGGCAACGGAATTCGAGTC
CTTCTCCCTGGACTCCACTTTCCACGCAAAGAAACAGATCCCGTGTATTGTGTCCATGCTCACGAAAGAACTGTA
CTTTTATCACTAG 
AT/CGAT 
AAGCTTATGCATGCGGCCGCATCTAGAGGGCCCGGATCCCGGGTGGCATCCCTGTGACCCCTCCCCAGTGCCTCT
CCTGGCCCTGGAAGTTGCCACTCCAGTGCCCACCAGCCTTGTCCTAATAAAATTAAGTTGCATCATTTTGTCTGA
CTAGGTGTCCTTCTATAATATTATGGGGTGGAGGGGGGTGGTATGGAGCAAGGGGCAAGTTGGGAAGACAACCTG
TAGGGCCTGCGGGGTCTATTGGGAACCAAGCTGGAGTGCAGTGGCACAATCTTGGCTCACTGCAATCTCCGCCTC
CTGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCGAGTTGTTGGGATTCCAGGCATGCATGACCAGGCTCAGCTA
ATTTTTGTTTTTTTGGTAGAGACGGGGTTTCACCATATTGGCCAGGCTGGTCTCCAACTCCTAATCTCAGGTGAT
CTACCCACCTTGGCCTCCCAAATTGCTGGGATTACAGGCGTGAACCACTGCTCCCTTCCCTGTCCTTCTGATTTT
AAAATAACTATACCAGCAGGAGGACGTCCAGACACAGCATAGGCTACCTGGCCATGCCCAACCGGTGGGACATTT
Suppl.: TdTomato (w/o TAA stop codon) + Kpn1 + GTT-Linker + 
CASP3 (w/ stop codon) inserted in pCMV5 MCS 
96 
GAGTTGCTTGCTTGGCACTGTCCTCTCATGCGTTGGGTCCACTCAGTAGATGCCTGTTGAATTGGGTACGCGGCC
AGCTTGGCTGTGGAATGTGTGTCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAG
CATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCAT
GCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGC
CATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGC‐3’ 
TRANSLATION (76 kDa): 
MVSKGEEVIKEFMRFKVRMEGSMNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFAWDILSPQFMYGSKAYVK
HPADIPDYKKLSFPEGFKWERVMNFEDGGLVTVTQDSSLQDGTLIYKVKMRGTNFPPDGPVMQKKTMGWEASTER
LYPRDGVLKGEIHQALKLKDGGHYLVEFKTIYMAKKPVQLPGYYYVDTKLDITSHNEDYTIVEQYERSEGRHHLF
LGHGTGSTGSGSSGTASSEDNNMAVIKEFMRFKVRMEGSMNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFA
WDILSPQFMYGSKAYVKHPADIPDYKKLSFPEGFKWERVMNFEDGGLVTVTQDSSLQDGTLIYKVKMRGTNFPPD
GPVMQKKTMGWEASTERLYPRDGVLKGEIHQALKLKDGGHYLVEFKTIYMAKKPVQLPGYYYVDTKLDITSHNED
YTIVEQYERSEGRHHLFLYGMDELYKGTTMENNKTSVDSKSINNFEVKTIHGSKSVDSGIYLDSSYKMDYPEMGI
CIIINNKNFHKSTGMSSRSGTDVDAANLRETFMGLKYQVRNKNDLTREDILELMDSVSKEDHSKRSSFVCVILSH
GDEGVIYGTNGPVELKKLTSFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGTDEEMACQKIAGGG* 
 
 
Suppl.: tdTomato (w/o TAA stop codon) + Kpn1 + Linker + partial 
IMPase sequence (w/ stop codon) inserted in pCMV5 MCS 
97 
green = tdTomato 
red = linker region 
blue = pIMPase 
 
5’‐ATAGAGAGCTCGTTTAGTGAACCGTCA 
G/AATTC 
GATGGTATGGTGAGCAAGGGCGAGGAGGTCATCAAAGAGTTCATGCGCTTCAAGGTGCGCATGGAGGGCTCCATG
AACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAG
GTGACCAAGGGCGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCCCAGTTCATGTACGGCTCCAAGGCGTAC
GTGAAGCACCCCGCCGACATCCCCGATTACAAGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATG
AACTTCGAGGACGGCGGTCTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCACGCTGATCTACAAGGTG
AAGATGCGCGGCACCAACTTCCCCCCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCACC
GAGCGCCTGTACCCCCGCGACGGCGTGCTGAAGGGCGAGATCCACCAGGCCCTGAAGCTGAAGGACGGCGGCCAC
TACCTGGTGGAGTTCAAGACCATCTACATGGCCAAGAAGCCCGTGCAACTGCCCGGCTACTACTACGTGGACACC
AAGCTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAGCGCTCCGAGGGCCGCCACCAC
CTGTTCCTGGGGCATGGCACCGGCAGCACCGGCAGCGGCAGCTCCGGCACCGCCTCCTCCGAGGACAACAACATG
GCCGTCATCAAAGAGTTCATGCGCTTCAAGGTGCGCATGGAGGGCTCCATGAACGGCCACGAGTTCGAGATCGAG
GGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGCGGCCCCCTGCCC
TTCGCCTGGGACATCCTGTCCCCCCAGTTCATGTACGGCTCCAAGGCGTACGTGAAGCACCCCGCCGACATCCCC
GATTACAAGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGTCTGGTG
ACCGTGACCCAGGACTCCTCCCTGCAGGACGGCACGCTGATCTACAAGGTGAAGATGCGCGGCACCAACTTCCCC
CCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCACCGAGCGCCTGTACCCCCGCGACGGC
GTGCTGAAGGGCGAGATCCACCAGGCCCTGAAGCTGAAGGACGGCGGCCACTACCTGGTGGAGTTCAAGACCATC
TACATGGCCAAGAAGCCCGTGCAACTGCCCGGCTACTACTACGTGGACACCAAGCTGGACATCACCTCCCACAAC
GAGGACTACACCATCGTGGAACAGTACGAGCGCTCCGAGGGCCGCCACCACCTGTTCCTGTACGGCATGGACGAG
CTGTACAAG 
GGTAC/C 
GGCACCGGCAGCGGCAGCGGCAGCGGCAGCACCGGC 
CTGGTGACCGTGACCGACCAGAAGGTGGAGAAGATGCTGATGAGCAGCATCAAGGAGAAGTACCCCTGCCACAGC
TTCATCGGCGAGGAGTGATAA 
AT/CGAT 
AAGCTTATGCATGCGGCCGCATCTAGAGGGCCCGGATCCCGGGTGGCATCCCTGTGACCCCTCCCCAGTGCCTCT
CCTGGCCCTGGAAGTTGCCACTCCAGTGCCCACCAGCCTTGTCCTAATAAAATTAAGTTGCATCATTTTGTCTGA
CTAGGTGTCCTTCTATAATATTATGGGGTGGAGGGGGGTGGTATGGAGCAAGGGGCAAGTTGGGAAGACAACCTG
TAGGGCCTGCGGGGTCTATTGGGAACCAAGCTGGAGTGCAGTGGCACAATCTTGGCTCACTGCAATCTCCGCCTC
CTGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCGAGTTGTTGGGATTCCAGGCATGCATGACCAGGCTCAGCTA
ATTTTTGTTTTTTTGGTAGAGACGGGGTTTCACCATATTGGCCAGGCTGGTCTCCAACTCCTAATCTCAGGTGAT
CTACCCACCTTGGCCTCCCAAATTGCTGGGATTACAGGCGTGAACCACTGCTCCCTTCCCTGTCCTTCTGATTTT
AAAATAACTATACCAGCAGGAGGACGTCCAGACACAGCATAGGCTACCTGGCCATGCCCAACCGGTGGGACATTT
GAGTTGCTTGCTTGGCACTGTCCTCTCATGCGTTGGGTCCACTCAGTAGATGCCTGTTGAATTGGGTACGCGGCC
AGCTTGGCTGTGGAATGTGTGTCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAG
CATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCAT
GCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCCGCCCAGTTCCGC
CCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGC‐3‘ 
 
 
 
Suppl.: tdTomato (w/o TAA stop codon) + Kpn1 + Linker + partial 
IMPase sequence (w/ stop codon) inserted in pCMV5 MCS 
98 
TRANSLATION (59 kDa): 
MVSKGEEVIKEFMRFKVRMEGSMNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFAWDILSPQFMYGSKAYVK
HPADIPDYKKLSFPEGFKWERVMNFEDGGLVTVTQDSSLQDGTLIYKVKMRGTNFPPDGPVMQKKTMGWEASTER
LYPRDGVLKGEIHQALKLKDGGHYLVEFKTIYMAKKPVQLPGYYYVDTKLDITSHNEDYTIVEQYERSEGRHHLF
LGHGTGSTGSGSSGTASSEDNNMAVIKEFMRFKVRMEGSMNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFA
WDILSPQFMYGSKAYVKHPADIPDYKKLSFPEGFKWERVMNFEDGGLVTVTQDSSLQDGTLIYKVKMRGTNFPPD
GPVMQKKTMGWEASTERLYPRDGVLKGEIHQALKLKDGGHYLVEFKTIYMAKKPVQLPGYYYVDTKLDITSHNED
YTIVEQYERSEGRHHLFLYGMDELYKGTGTGSGSGSGSTGLVTVTDQKVEKMLMSSIKEKYPCHSFIGEE* 
 
 
